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ABSTRACT

Determination of the Expression Patterns of Bovine Non-Classical Major Histocompatibility
Complex (MHC) Class I Proteins

by

Parveen Parasar, Doctor of Philosophy
Utah State University, 2013

Major Professor: Dr. Christopher J. Davies
Department: Animal, Dairy and Veterinary Sciences

My dissertation hypothesis is that bovine trophoblast cells express cell-surface and
secreted non-classical major histocompatibility complex class I (MHC-Ib) proteins which inhibit
NK cells and other leukocytes by binding to inhibitory receptors (e.g., LILRB1, LILRB2,
KIR2DL4, and/or CD94/NKG2A).
Extremely polymorphic and ubiquitously expressed classical MHC class I (MHC-Ia)
proteins, which present foreign antigenic peptides to CD8+ T lymphocytes, are involved in
acceptance or rejection of tissue grafts. Non-classical MHC class I (MHC-Ib) glycoproteins, such
as Human Leukocyte Antigen-G (HLA-G) and murine Qa-2, are important modulators of the
maternal immune system during pregnancy. MHC-Ib proteins are: (a) oligomorphic or
monomorphic, (b) expressed in specific tissues under specific condtions, and (c) produced as
surface and/or soluble isoforms due to alternative splicing.
Third trimester-bovine trophoblast cells express both MHC-Ia and MHC-Ib proteins. The
MHC-Ib proteins expressed by trophoblast cells during the third trimester of pregnancy are
encoded by four bovine leukocyte antigen (BoLA) loci: BoLA-NC1, BoLA-NC2, BoLA-NC3,
and BoLA-NC4.
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Two MHC-Ia (N*01701 and N*01802) and three MHC-Ib (NC1*00501, NC3*00101 and
NC4*00201) proteins showed cell-surface expression in transfection studies performed in murine
P815 and human K562 cells. Two additional isoforms, NC1*00401 and NC2*00102, were not
detected on the surface of these cells. Nevertheless, both class Ia proteins, N*01701 and
N*01802, and five class Ib proteins, NC1*00401, NC1*00501, NC2*00102, NC3*00101, and
NC4*00201, were detected in crude cell lysates on Western blots. Precipitation of proteins from
culture supernatants showed that cell-surface MHC-Ia (N*01701 and N*01802) and MHC-Ib
proteins (NC1*00501, NC3*00101, and NC4*00201) are shed from the surface of these cells into
the media. The mechanism of shedding of these proteins is, however, not known.
Monoclonal antibodies W6/32, IL-A88, H1A, H6A, H11A, H58A, and PT-85A
recognized surface MHC-I isoforms with varying affinity. We were able to develop a sandwich
enzyme-linked immunosorbent assay (ELISA) using either H1A or IL-A88 antibody as the
capture antibody and the W6/32 antibody for detection. We produced monoclonal antibodies
against cattle NC1*00501 and NC3*00101 proteins. One monoclonal antibody generated against
BoLA-NC3*00101 was highly specific. Unfortunately, due to failure to clone the NC3*00101hybridoma, we no longer have an infinite source of this monoclonal antibody for NC3*00101.
We eluted peptides from NC3*00101-transfected MHC-null K562 cells and identified peptides
using liquid chromatography-mass spectrum (LC-MS) analysis. Analysis of peptide binding data
using the SAS Proc mixed statistical program, suggested that the peptide EVTNQLVVL is a
potential peptide ligand, which can be used to make tetramers for enumeration of antigen-specific
leukocytes.

(148 pages)
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PUBLIC ABSTRACT

Determination of the Expression Patterns of Bovine Non-Classical Major Histocompatibility
Complex (MHC) Class I Proteins

Parveen Parasar

This project was funded by the United States of Department of Agriculture (USDA),
which funds research aimed at improving production and animal health. The aim of this study
was to advance knowledge of maternal immune tolerance to the fetus and mechanisms bovine
non-classical MHC class I proteins employ to interact with immune cells and render them inert
towards the fetus.
A fetus is a tissue graft inside the mother’s uterus yet must be accepted by the mother to
maintain a successful pregnancy. Reproductive insufficiency and pregnancy failure are major
causes of production loss in cattle, especially in cloned animals. Knowledge of the receptors that
non-classical MHC class I proteins interact with may make it possible to improve reproductive
efficiency in cattle. We have shown that three non-classical MHC class I proteins expressed
during the third trimester, NC1*00501, NC3*00101, and NC4*00201, are expressed as cellsurface isoforms. The other non-classical class I proteins, that we studied, NC1*00401 and
NC2*00102, were not expressed on the surface of our cell lines and may be secreted or soluble
proteins. The non-classical class I proteins expressed and/or secreted by embryos at different
gestational stages can be detected using enzyme-linked immunosorbent assays (ELISA). We were
able to produce a NC3*00101-specific monoclonal antibody for use in ELISA; however, we lost
the cell line when we attempted to clone it.
Understanding the patterns of expression of these proteins during different stages of
pregnancy will help elucidate the association of these proteins with pregnancy success in normal
and cloned cattle and will provide insights into mechanisms that prevent rejection of the fetus by
the potentially hostile maternal immune system. To elucidate how non-classical class I proteins
interact with white blood cells in the uterus, we initiated studies to identify NC3*00101-specific
peptide ligands needed to make NC3*00101 tetramers, which can be used to understand
interactions between MHC molecules and white blood cells. Understanding the interactions of
non-classical class I proteins with maternal immune cells will reveal the mechanisms of
inhibitory action that are used by class Ib proteins to suppress the maternal immune system and
protect the fetus.
This study helped to elucidate patterns of expression of cattle non-classical MHC class I
proteins, which are important to maintain a favorable environment within uterus during
pregnancy.
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CHAPTER 1
LITERATURE REVIEW

Pregnancy includes the complex steps of fertilization, cleavage of newly formed
zygote by mitotic divisions to form the embryo (morula), blastocyst (blastula), and
gastrula, and organogenesis resulting in a fully developed fetus. The average gestation
time in cattle is 285 days. The blastocyst develops at ~7th day and hatches 8-9 days postconception. After gastrula formation (16-18th day post-conception) and elongation,
embryo implantation begins at ~22 days and completes in ~40 days post-conception.
Despite its allogeneic nature and its antigenicity, a fetus is carried to term with successful
completion of each of these complex steps of pregnancy without being rejected by the
maternal immune system.
The Major Histocompatibility Complex (MHC) is the genetic region that encodes
the transplantation antigens or MHC class I (MHC-I) and MHC class II (MHC-II)
molecules, which are primarily involved in protecting the body against pathogens.
Immunological recognition of pathogens includes proteolysis of foreign proteins into
peptides, assembly of peptides on MHC-I and -II glycoproteins specialized for presenting
the peptides on the cell-surface, and interaction of the MHC-I and MHC-II-peptide
complexes with CD8 and CD4 T cell-receptors, respectively, leading to effector functions
including subsequent killing or removal of the infected cells to clear the infection.
Because MHC glycoproteins present peptides, they play an important role in the
acceptance or rejection of the tissue grafts. A successful pregnancy requires that the fetal
allograft remains unharmed by the mother’s potentially hostile immune system
throughout pregnancy. In humans and mice, studies indicate that another class of
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transplantation antigens, referred to as “non-classical MHC class I (MHC-Ib) proteins,”
are expressed as alternatively spliced isoforms in fetal trophoblast cells and interact with
inhibitory receptors on natural killer cells and other maternal leukocytes resulting in the
inhibition of these cells. Examples of class Ib proteins are human leukocyte antigens
(HLA)-E, -F and -G, Qa-2 in mice, Mamu-AG in Rhesus Macaques, and Paan-AG in
olive baboons.
After years of research on immune tolerance to the fetus during pregnancy, novel
mechanisms of interaction of MHC-Ib proteins with receptors on maternal leukocytes
have been identified in humans and mice. In cattle, identification of bovine leukocyte
antigen (BoLA) class Ib proteins begs further research to investigate the mechanisms of
bovine maternal-fetal immune-regulation during pregnancy and achievement of an
immunologically tolerant state in the uterus.

The Structure of MHC Glycoproteins
Histocompatibility genes, which produce transplantation or histocompatibility
antigens, were first discovered in mice [58]. This finding led to the identification of loci
encoding human and mouse [59, 60, 110]. MHC class I antigens and successful organ
transplantation in patients. The genes that encode MHC proteins and several other
proteins with related functions are tightly linked in the MHC genetic region. The human
MHC, human leukocyte antigen (HLA) complex, and mouse MHC, the H-2 complex, are
located on chromosomes 6 and 17, respectively. The bovine MHC, which is known as the
bovine leukocyte antigen “(BoLA) complex,” is located on bovine autosome 23. The
genetic structure of BoLA was first described by Amerona and Stone (1978) and Spooner
et al. [105, 106].
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There are two classes of MHC glycoproteins: MHC-I and MHC-II. Class I
proteins comprise an alpha (α) polypeptide chain which is a large subunit of 44 kilodaltons (D) molecular weight (MW) that is non-covalently linked with a 12 kD-light
chain called β2 microglobulin (β2m) to form a stable cell surface protein. The gene for the
β2m is not located in the MHC region. MHC-II proteins are heterodimers composed of an
alpha (α) and a beta (β) polypeptide chain. Class II molecules are expressed on
professional antigen presenting cells (APCs) such as dendritic cells (DCs), macrophages
and B cells. Class II molecules are not expressed on placental trophoblast cells and,
therefore, will not be described in detail here.
The general structure of the MHC in mammalian species is relatively conserved.
The BoLA complex is divided into three regions - BoLA-I, BoLA-II and BoLA-III with
different functions and roles. There are at least six classical MHC-I genes in the BoLA-I
region which are expressed in a number of different combinations [11]. In addition, the
BoLA-I region contains four non-classical BoLA-class I loci, NC1-NC4 [25].
BoLA-II was subdivided into BoLA-IIa and -IIb based on genetic mapping [5, 119]. The
BoLA-IIa subregion contains the DR and DQ cluster of genes [4, 98]. The BoLA-IIb and
BoLA-IIa subregions are about 15cM apart. The BoLA-IIb subregion includes the DMA,
DMB, LMP2, LMP7 and TAP genes whose products are involved in antigen processing
and transport [22, 66, 92]. The class IIb region also carries some other genes of unknown
function such as DOA, DOB, DYA and DYB [66].
The BoLA-III region contains genes such as CYP21, BF, HSP70 and C4 which
are not considered part of the MHC proper [6, 66]. Figure 1-1 shows the linkage map of
bovine MHC genetic regions as reported earlier [3].
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Fig 1-1 Genetic linkage map of the major histocompatibility complex (MHC) region in
cattle

Classical (MHC-Ia) and Non-classical (MHC-Ib) MHC-I Proteins
MHC-Ia proteins show ubiquitous expression. They are absent from mature
erythrocytes of larger mammals such as humans and pigs but in rodents they are present
on erythrocytes at low density. The MHC-Ia molecules are extremely polymorphic with a
large number of alleles present in the population. These proteins are transmembrane
glycoproteins and play an important role in immune regulation.
MHC-Ib genes are monomorphic or oligomorphic and often possess premature
stop codons, and/or putative non-classical amino acid motifs (IPI and VPI) in the
transmembrane domain. Similar to class Ia genes, most class Ib genes have eight exons
which encode the heavy chain. Exon 1 encodes the signal sequence that is cleaved after
the newly synthesized protein is targeted into the endoplasmic reticulum (ER). Exons 2, 3
and 4 encode the α1, α2 and α3 domains, which form the extracellular portion of the
protein. The transmembrane domain is encoded by exon 5. Exons 6, 7, and sometimes
part of exon 8 encode the cytoplasmic domain. In contrast to MHC-Ia proteins, nonclassical class I proteins (MHC-Ib) are expressed in specific tissues and under specific
conditions. These proteins often have a truncated cytoplasmic domain. As a result of
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alternative splicing, these proteins are produced as transmembrane and soluble isoforms
[49]. The process of alternative splicing determines the secreted or lipid-linked nature of
some class Ib molecules such as HLA-G (HLA-G2) and Qa-2 [50]. Alternative splicing
of HLA-G or Qa-2 transcripts that eliminates or splices out exon 5, results in only
secreted isoforms. In contrast to class Ia molecules which require binding with a light
chain or β2-microglobulin (β2m) for their cell-surface expression [51, 95, 115, 116],
MHC-Ib proteins do not always require a light chain for their expression. MembraneHLA-G1 and soluble HLA-G5 associate with a light chain whereas membrane HLA-G2
and –G3 and soluble HLA-G6 do not associate with a light chain or β2m [49].

Peptide Binding to MHC Glycoproteins
MHC class I proteins bind peptides from intracellular pathogens and the animal’s
own protein-derived peptides. The protein complexes are digested in the cytosol by
proteasomes into 8-10 amino acid long peptides [71]. These peptides are accommodated
in the peptide-binding cleft formed by the α1 and α2 domains of MHC-I proteins. The Ntermini of freshly synthesized MHC-I glycoproteins contain N-linked glycan. N-linked
glycans are trimmed by Glucosidases I and II (GlsI/II) to a single terminal glucose
residue, which allows the MHC-I protein to interact with chaperon proteins. After this,
the first interaction is with calnexin (CNX), which allows β2m to bind with the MHC-I
heavy chain. Calreticulin (CRT) then recruits the MHC- protein to the peptide loading
complex (PLC) [94]. The PLC is formed by the transporter associated with antigen
processing (TAP) heterodimer together with other proteins and chaperon molecules.
Tapasin, Erp 57, and CRT in association with other chaperons in the PLC help to locate
the MHC-I protein to the PLC. Peptides longer than 8-10 amino acids are trimmed by ER
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aminopeptidases known as “ERAAP/ERAP1 and ERAP2.” Finally, tapasin-mediated
editing results in preferential binding of approximately sized peptides in the peptidebinding groove [28, 79, 80, 112]. The MHC-I-peptide complexes then move to the cell
surface for recognition by T cell-receptors on CD8+ T lymphocytes.
MHC-II glycoproteins bind peptides derived from endocytosed extracellular
proteins. The α and β chains of class II proteins associate with the invariant chain (Ii
chain) and the complex moves to a mature endosome via the trans-Golgi network (TGN).
In mature endosomes, the invariant chain is cleaved by proteolysis to form the class II
associated invariant chain peptide (CLIP) [18, 37, 55, 63, 78, 83, 109, 127]. Endocytosed
proteins internalized by a cell from exogenous sources are degraded in increasingly acidic
and proteolytic endosomal compartments of early and late endosomes, and lysosomes by
acidic lysosomal proteases called cathepsins into peptides [123]. The MHC-II-related
chaperons such as HLA-DM and HLA-DO are expressed in the ER and form complex.
DM-DO complexes co-transport to late endosomes, where DM catalyzes the replacement
of the CLIP fragment in the MHC-II binding groove by exogenous peptides [26, 70, 73,
74]. The DM protein regulates the binding of high-affinity peptides to MHC-II [100]. The
MHC-II-peptide complexes move to the cell surface for recognition by the CD4+ T cells.

MHC Glycoproteins and Transplantation
The process of recognition of self and foreign peptides by T lymphocytes was
first studied in mice [128]. The findings demonstrated that cytotoxic T lymphocytes lyse
virus-infected cells under specific immunological conditions. Virus-infected target cells
are killed only when they carry the same MHC-I antigens as the immune T cells, which
explains MHC-mediated restriction of T lymphocyte function. The researchers reported
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that virus-infected cellular targets of cytotoxic T lymphocytes contain two parts, the viral
antigen and the MHC-I antigen. Similar studies revealed that MHC-II antigens on APCs
must be the same as the MHC-II proteins that primed the T lymphocyte in order for the T
cells to recognize the antigens. They found that T helper cells only recognize antigens on
the surface of APCs and the class II molecule is part of the antigenic complex recognized
by the T helper cells [101, 113]. Therefore, the MHC molecules, both class I and II,
govern the effector functions of cytotoxic and helper T cells, respectively. MHC-I and
MHC-II polymorphism have been associated with susceptibility and resistance to many
pathological conditions [21, 27]. Certain alleles are more frequent in one population than
in another. One consequence of the MHC-I and MHC-II polymorphism is that when a
diseased organ is replaced by transplantation of a healthy organ, the new organ may be
accepted or rejected based on the degree of similarity between the class I and class II
antigens on the cells of the donor and recipient tissues.
It is helpful to understand the following terms that describe transplantation
between animals:
Autograft - A tissue graft where the tissue is transplanted back onto the original donor.
Isograft - A graft between individuals of identical genetic composition (i.e. syngeneic
individuals) such as identical twins or mice of the same inbred mouse line.
Allograft – A graft between individuals of the same species but of different genetic
compositions (i.e., allogeneic individuals) such as human to human and from one strain
of mouse to another.
Xenograft – A graft between members of different species (i.e., xenogeneic individuals)
such as a graft from a monkey to human.
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The greatest concern is with allografts because allografting is commonly practiced
for treatment of many human disorders. Blood transfusions as well as skin, kidney, liver,
and other organ transplants are all examples of allografts. An allogeneic skin graft is
sloughed within 10 days due to the infiltration of the graft bed with lymphocytes,
monocytes and a few plasma cells. The second time, a graft from the same donor is
rejected much faster than the first time and there is more infiltration with
polymorphonuclear leukocytes, lymphoid cells, and plasma cells, including thrombosis
and acute cell destruction. Therefore, the second-set rejection is more severe than the
first-set rejection. Grafts from new donors are rejected at the same rate as the original
first-set rejection. The presence of immunological memory suggests that graft rejection is
mediated by lymphocytes. Transplantation rejection can be prevented or delayed by
matching the MHC class I and class II antigens of the donor and recipient. Another
method of preventing graft rejection is to use immunosuppressive drugs that inhibit T
lymphocyte activation.

Fetal Allograft and Placentation in Cattle
Despite its allogeneic nature, the fetal allograft is not normally rejected by the
potentially hostile maternal immune system. The early embryo is made of blastomeres
which are undifferentiated cells resulting from cleavage of the fertilized egg (zygote).
After a series of divisions and compaction, the embryo forms a compact mass of 16-32
blastomeres known as the morula. The morula develops into a fluid-filled hollow ball of
over a hundred cells known as the blastocyst. A blastocyst has two distinctive tissues, the
outer single-cell layer of trophectoderm or trophoblasts surrounding the fluid-filled cavity
(blastocoel) which gives rise to extra-embryonic tissues and the inner cell mass gives rise
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to the embryonic disc and eventually the embryo proper. Together with the somatic
mesoderm, the trophoblast layer is referred to as the “chorion.”
In cows, the gestation length is 285 days and the chorioallantois starts attaching to
the gravid uterus at about 4 weeks of gestation. With the growth of extraembryonic
membranes inside the uterine lumen chorioallantois starts to form “cotyledons” over
specialized areas of the endometrium known as “caruncles.” The caruncular surface
develops crypts and the apposing chorioallantois forms finger-like projections, which
enter into the crypts, greatly enhancing the contact surface area between the endometrium
and the trophoblast [97]. The combination of cotyledonary and caruncular tissues forms
the “placentomes.” Placentomes are 10-12 cm long and 2-3 cm thick. The chorioallantois
that develops and apposes with endometrium between placentomes is the
interplacentomal chorioallantois. The chorioallantois, both cotyledonary and
intercotyledonary, is responsible for nutrient uptake that provides for the fetal metabolic
demands and fetal tissue growth. This type of placenta is known as a “cotyledonary
placenta” and is found in ruminants. The majority of ruminant trophoblast cells is
uninucleate and functions in nutrient exchange and metabolism. An important feature of
the ruminant-placenta is the presence of binucleate cells (BNC) or giant trophoblast cells,
which develop by acytokinetic mitosis of uninucleate trophoblast cells. Binucleate cells
constitute 15-20% of the bovine trophoblast cells. Binucleate trophoblast cells fuse with
uterine epithelial cells both in the placentomes and the interplacentomal region to form
trinucleate cells, which are feto-maternal hybrids, throughout pregnancy [61, 124]. BNC
secrete bovine pregnancy-associated glycoproteins (PAGs) [125], progesterone,
transforming growth factor-β (TGF-β), and placental lactogen which act as local
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immunomodulators to maintain pregnancy as well as help in the metabolism and
development of placentomes [34, 75, 89, 90].
Ruminant placenta is often referred to as “synepitheliochorial”. The bovine
chorion (trophoblast) layer is in intimate contact with the maternal epithelium. The
binucleate cells migrate toward the uterine epithelium and fuse with the epithelial cells,
secreting their granules to the basal side of the uterus. These secretory granules provide a
mechanism for transfer of MHC-I proteins to the maternal side of the placenta. The γδ-T
cells also have been identified in the uterine epithelium during pregnancy in ruminants
[64, 68, 85]. These cells may play a role in the development of the conceptus,
immunosuppression, and placental detachment during parturition.

The Role of MHC Class I Proteins in Reproduction
In most species, mature trophoblast cells do not express highly polymorphic
classical class I protein [33, 40, 48]. Fetal allografts expressing classical class I proteins
during the first trimester of pregnancy do not survive in the uterus [9]. In ewes, a study
showed that intrauterine skin autografts were immunologically accepted, whereas the
allografts were rejected [88].
In cattle, trophoblast cells in interplacentomal, arcade, and villous/crypt regions
possess unique MHC-I expression patterns. In normal pregnancy, cattle trophoblasts do
not show MHC-I expression before 120 days of pregnancy. However, MHC-I expression
by interplacentomal and arcade trophoblast cells during the last trimester in cattle is
normal [23]. Cows carrying MHC-compatible pregnancies at term have reduced levels of
immunoreactive interleukin-2 (IL-2), less apoptosis, less tumor necrosis factor-alpha
(TNF-α) in macrophages, and reduced degranulation of binucleate trophoblast cells,
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which is similar to the conditions seen with retained placenta [24]. In the third trimester
of pregnancy, MHC class Ia and class Ib proteins are expressed in the interplacentomal
and arcade regions [25]. The ratio of class Ia to class Ib gene expression varies
extensively among pregnancies. About 34-79% of transcripts from interplacentomal
trophoblast cells are encoded by class Ib genes. Gene sequence analysis led to the
discovery of four bovine non-classical loci: BoLA-NC1, BoLA-NC2, BoLA-NC3, and
BoLA-NC4.
Normally, cattle have a greater number of lymphocytes in the non-gravid uterine
horn than in the gravid horn. In early pregnancy, the endometrial lymphocytes decrease
in number in sheep, pigs, and cattle [12, 57, 64, 122]. In 34-63 day old SCNT
pregnancies, trophoblast MHC-I expression was widespread and accompanied by
endometrial infiltration of CD3+ T lymphocyte that formed aggregates as compared to
normal pregnancies [45]. This maternal lymphocytic response involved 80% CD4+
helper T cells, with the remaining cells comprised of equal numbers of CD8+ cytotoxic T
cells and B cells with a minimal number of γ/δ-T lymphocytes (Davies unpublished). The
large number of CD4+ T helper cells suggests that allogeneic trophoblast MHC-I proteins
are processed by maternal antigen presenting cells (APCs) and that MHC-I derived fetal
peptides are presented on maternal MHC class II proteins. This is an indirect recognition
pathway, where recognition is restricted by the host MHC class II molecules that have
bound peptides derived from an allogeneic MHC molecule [43]. Fetal antigens are
probably carried towards the uterine endometrial epithelium by binucleate cells and
released with the secretory granules after the BNC fuse with the uterine epithelial cells.
Presentation of peptides derived from fetal MHC-Ia antigens triggers recruitment of Th1
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cells and initiation of an inflammatory response involving release of tumor necrosis
factor (TNF)-α, interleukin (IL)-1β, IL-12, and IFN-γ, which interferes with placental
attachment and causes embryonic death. The success rate of nuclear transfer in cattle
ranges from 0% to 10% [114].
These findings suggest that abnormal trophoblast MHC-I expression accompanied
by lymphocytic infiltration of the endometrium causes early embryonic mortality of
cloned fetuses. Therefore, appropriate expression of fetal MHC-I antigens at the bovine
fetal-maternal interface is critically important for immunological acceptance of the
allogeneic fetus by its mother.

Non-classical MHC-I (MHC-Ib) Proteins and Tolerance to the Fetal-allograft
The mystery of immunological acceptance of the fetal allograft has been the focus
of many studies. There are various mechanisms that induce maternal tolerance. These
include production of TGF-β1 and interleukin-10 (IL-10) by the Treg subset of
CD4+/CD25 cells, secretion of prolactin, gonadotropin and progesterone by both fetal
and endometrial cells, and expression of high levels of complement regulatory proteins
by fetal cells and expression of inhibitory members of the B7 and the TNF family of
ligands [19, 49, 95]. Fetal cells also produce immunosuppressive cytokines, chemokines,
and prostaglandins, which dampen T lymphocyte proliferation, and secrete the
immunosuppressive hormone progesterone. Importantly, trophoblast cells regulate the
expression of MHC-Ia and MHC-Ib proteins [23, 24, 25]. As mentioned earlier, villous
trophoblast cells do not express class Ia and class II molecules. However, in cattle
interplacentomal and arcade trophoblast cells express class I proteins during the second
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and third trimesters of pregnancy. MHC-Ib proteins are uniquely expressed in human,
mouse, rhesus macaques, baboons, and cattle trophoblast cells.
HLA-E, HLA-F, and HLA-G are human class Ib proteins and Qa-1 and Qa-2 are
murine class Ib proteins are. Similar class Ib proteins studied in non-human primates
include Mamu-AG in Macaca mulata and Paan-AG in olive baboons. HLA-G and Qa-2
proteins have been studied most extensively for their role in maternal tolerance to fetal
allografts [20, 35]. HLA-G is predominantly expressed on fetal extravillous trophoblasts
[35, 62]. HLA-G provides inhibitory signals to NK cells, macrophages, monocytes, and
lymphocytes by interacting with various inhibitory recetors expressed by leukocytes to
induce immunosuppression and fetal survival [49]. These receptors are inhibitory
leukocyte immunoglobulin-like receptors 1 and 2 (LILRB1/LIR-1/ ILT-2 and LILRB2/LIR-2/ILT-4), CD94/NKG2A, and killer-immunoglobulin-like receptor (KIR) 2DL4
(KIR2DL4) [2, 7, 38, 65, 84, 86, 102, 104].
Murine Q9 antigen (referred to as Qa-2) of the Qa-2 family of proteins is encoded
at the Ped (preimplantation embryonic development) gene locus. It was recognized
because of its role in embryonic development and reproductive tolerance. The murine Q9
antigen is a functional homologue of HLA-G [20]. Both HLA-G and Qa-2 play a role in
tumor surveillance via peptide presentation to CD8+ T cells [41]. HLA-G and Qa-2 can
present a larger array of peptides than HLA-E and Qa-1 [54, 91, 111]. HLA-G can
display restricted but still a diverse set of peptides [29, 52]. HLA-G has two free cysteine
residues (Cys42 and Cys142) unlike most of other MHC-I alleles. Both soluble and cellsurface HLA-G isoforms can exist as disulfide-linked dimer with intermolecular Cys42Cys42 disulfide bond. The HLA-G dimer has oblique orientation which exposes the
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receptor-binding sites upward and more accessible. HLA-G dimer has much higher
overall affinity toward LILRBs than the monomer because it has increased avidity for its
ligand [15, 103]. The HLA-G dimer on the cell surface inhibits NK cells through LILRB1
binding [42]. The peptide binding surfaces of each HLA-G monomer is too small to be
accessible by T cell receptor; therefore, it cannot work as antigen presenting molecule for
the T cell response. However, it can present LILR- and CD8- binding sites, which
suggests that HLA-G dimers are important in immunosuppression.
HLA-E and Qa-1 are orthologues and present peptides derived from the leader
sequences of other class I molecules [16, 53]. HLA-E and Qa-1 play a role in the innate
immune response as ligands for the receptors of the CD94/NKG2 family expressed by
NK and T cells [17, 120]. In some bacterial and viral infections, class Ia proteins are
downregulated. Due to non-availability of leader sequence, HLA-E and Qa-1 are not
expressed properly. NK cells can detect and eliminate the compromised MHC deficient
host cells [1].
Cattle have two MHC clusters that are equivalent to the human MHC-I beta and
kappa blocks. The orthologous MHC-I region in cattle carries the heavy chain genes for
BoLA-NC2, -NC3, and -NC4. The only expressed MHC-I gene in the orthologous human
kappa block is HLA-E. In addition, this block contains six to eight MHC-Ia genes and
expresses two to three MHC-Ia proteins. The cattle orthologo kappa block has one
expressed MHC-Ib gene, BoLA-NC1 (Davies unpublished), that maps very close to
HLA-E, which suggests that these genes can be true orthologs.
In Rhesus monkeys, an ortholog of HLA-G named “Mamu-G” was identified in
trophoblast cells from a day-36 post-conception placenta [13]. This class Ib protein is
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non-functional as it contained premature stop codons and frameshift mutations.
Therefore, it is encoded by a pseudogene. Another non-classical molecule expressed
exclusively in rhesus monkey placenta, Mamu-AG, shares functional similarities with
HLA-G [14]. It has both membrane and soluble isoforms as a result of alternative
splicing [93].

Peptide Presentation by Non-classical MHC-I Proteins
Human and murine class Ib proteins have been extensively studied for their
peptide-presenting characteristics. Generally, class Ib molecules have peptide-presenting
capacity, which varies among all the expressed class Ib molecules [29, 99]. Compared to
class Ia molecules, class Ib molecules present a far narrower range of peptides, which
correlates well with their narrow tissue distribution. HLA-G molecules present nonamer
peptides, which are similar to those of class Ia molecules. The anchor residues for HLAG are isoleucine (I) or leucine (L) at position 2, proline (P) at position 3, and leucine at
position 9. HLA-G has a preference for non-anchor residues. For instance, position 1 is
generally positively charged and position 7 is a hydrophobic amino acid residue in most
of the ligand motifs [87]. Therefore, HLA-G glycoproteins which present the specific
sequence motif with the consensus sequence XI/LPXXXXXL resemble classical MHC
class I proteins [96]. Because HLA-G interacts with NK cell inhibitory receptors and
provides a signal peptide for increased expression of HLA-E, it inhibits the NK cells that
express C-type lectin like inhibitory receptors [76, 77].
The murine class Ib molecule Qa-2 binds with specifically histidine-containing
nonapeptides (9-amino acids long) with two anchor residues, Histidine (H) at position 7
and Leucine, Isoleucine (I) or Phenylalanine (F) at position 9 [91]. Positions 2, 3, 5, and 6
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are auxiliary anchors occupied by aliphatic residues. This suggests that a relatively small
number of nonapeptides fit the Qa-2 motif compared to the large number of peptides that
bind to other class I proteins; however, Qa-2 binds with a large array of endogenous
peptides [54, 91].
Peptide binding information is helpful to determine the physiological and
immunological role of class Ib proteins, which are expressed in tissues under specific
conditions. The peptide motif for BoLA class Ia protein, BoLA-N*01701, has been
identified [8, 39], but BoLA-Ib peptide motifs have not yet been identified.

Bovine MHC-Ib (BoLA-Ib) Proteins
Transcripts from four bovine non-classical class I loci, BoLA-NC1, BoLA-NC2,
BoLA-NC3 and BoLA-NC4 were identified [25] in third trimester-interplacentomal and
arcade region trophoblast cells. Amino acid alignment of class Ia and class Ib alleles at
the four BoLA-NC loci revealed that all of the BoLA-Ib alleles possess characteristic
features such as limited or no polymorphism, putative non-classical amino acid motifs
(IPI, VPI or VLI) in the transmembrane domain, differential splicing in the
transmembrane domain, and/or premature stop codons.
The BoLA-NC1 locus encodes seven alleles. The NC1*00101 allele has already
been described [46]. NC1*00201 (AH19), NC1*00301(AH12), and NC1*00401(AH11)
were identified by Davies et al. (2006) [25]. Most recently NC1*00501, NC1*00601, and
NC1*00701 alleles have been identified (Davies et al. unpublished). Multiple NC1 splice
variants with partial or complete deletion of exon 5, which encodes the transmembrane
domain, have been identified. Examples include NC1*00101 SV, NC1*00201,
NC1*00202 SV, and NC1*00401
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(http://www.ebi.ac.uk/ipd/mhc/bola/nomenclature.html). These splice variants suggest
that both membrane-bound and soluble isoforms are encoded at this locus.
The NC2 locus exhibits minimal polymorphism with only three closely related
alleles identified: NC2*00101 [36], NC2*00102 [25], and NC2*00103 (Davies et al.
unpublished).
NC3 and NC4 were new loci identified by Davies et al. (2006) [25]. The NC3
locus appears to be monomorphic and encodes an allele NC3*00101 that has an early
stop codon resulting in a truncated cytoplasmic domain. Four alleles have been identified
at the NC4 locus: NC4*00101 (AH12), NC4*00201 (AH11), NC4*00202 and
NC4*00301. The NC4 locus may not be expressed in all haplotypes. The variation in the
ratio of expression of classical to non-classical gene expression in trophoblast cells
appears to be influenced by the haplotype composition of the fetus. Haplotypes that have
a higher ratio of non-classical class I expression may be associated with higher
immunological acceptance of the fetal allograft.

Receptors for MHC-Ib Ligands
MHC-Ib proteins interact with inhibitory and activating receptors expressed on
maternal leukocytes and direct the actions of the leukocytes. NK cell receptors are
encoded at two genetic regions, the natural killer complex (NKC) and the leukocyte
receptor complex (LRC). The NKC on bovine Chr5, murine Chr6, and human Chr12
encodes killer cell lectin-like receptors such as inhibitory and activating members of the
CD94/NKG2 receptor family. These are expressed as heterodimers; CD94 combines with
various NKG2 isoforms to form functional receptors. The NKG2A isoforms have
immunoreceptor tyrosine-based inhibitory motifs (ITIM), whereas NKG2B and NKG2C
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isoforms have immunoreceptor tyrosine-based activating motifs (ITAM). Human HLA-E
interacts with CD94/NKG2A, B, and C receptors [17, 49, 50, 82]. Similarly, murine Qa-1
binds with CD94/NKG2C and CD94/NKG2E activating receptors on NK cells [67, 121].
There are two CD94 genes, seven NKG2A genes, and one NKG2C gene expressed in
cattle [10]. In rodents, the NKC also encodes the Ly49 family of receptors [126]. The
Ly49 receptors are homodimeric type-II C type lectin-like molecules [30]. In cattle, a
single Ly49 locus has been identified that is polymorphic and produces three alternatively
spliced Ly49 receptors. These receptors were reported to be inhibitory as reported earlier.
They therefore may act as inhibitory receptors for NK cells [32, 72].
The other genetic region, the LRC present on bovine Chr18, human Chr19, and
murine Chr7, encodes three types of receptors: the killer immunoglobulin-like receptors
(KIR), the leukocyte immunoglobulin-like receptors (LILR), and the leukocyteassociated immunoglobulin-like receptors (LAIR). The KIR in primates are functional
homologues of the Ly49 receptors in rodents [56, 81, 115]. Both KIR in primates and
Ly49 receptors in rodents are highly polymorphic with unique combinations of alleles
expressed on NK cells in different individuals [117, 118]. Killer Immunoglobulin-like
receptors recognize mostly MHC-Ia proteins [72]. In cattle, multiple KIR members have
been demonstrated [107, 108]. Soluble HLA-G binds with KIR2DL4 present on NK cells
and activates the NK cells. KIR2DL4 is predominantly localized in endosomes. Soluble
HLA-G is thus endocytosed to interact with KIR2DL4. Interaction between sHLA-G and
KIR2DL4 activates a proangiogenic response, which supports a role for soluble HLA-G
in augmenting vascularization early in pregnancy. KIR2DL4 possesses structural
elements associated with both the activation and inhibition of NK cells [81]. In addition
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to HLA-G, human trophoblasts express HLA-C, but not HLA-A or -B [69]. HLA-G and
HLA-C binding with KIR on human NK cells promotes conversion of maternal spiral
arteries into blood and nutrient-supplying channels to the placenta [44].

Summary
There is extensive literature on the role of MHC-Ib proteins in inducing maternal
immune tolerance to the fetus. This literature is the basis for my research to better
understand the mechanism of immune regulation at the maternal-fetal interface during
bovine pregnancy. Fetal-allografts are immunologically accepted in normal pregnancies.
Evidence of expression of class Ib molecules by human and murine trophoblast cells and
their role in inducing immune tolerance by reacting with the inhibitory receptors
expressed on different leukocytes have been reported. Therefore, cattle class Ib proteins
are potentially key players in immunomodulation at the maternal-fetal interface.
Identification of the expression patterns of the bovine trophoblast class Ib proteins and
their peptide binding motifs will help identify pathways these proteins use to maintain
maternal immunological tolerance to fetus.

Research Impact and Applications
This research project is based on the hypothesis that cattle MHC class Ib proteins
are produced as surface and/or secreted isoforms and they interact with maternal NK cells
and other leukocytes to provide an immunological state within the uterus favorable for
maintenance of the fetus.
The research addressed the following specific aims:
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1)

Determine which bovine class Ib proteins are produced as transmembrane

proteins and/or secreted isoforms.
2)

Develop or identify monoclonal antibodies specific for BoLA-Ib proteins

3)

Determine peptide motifs recognized by BoLA-Ib proteins and to make BoLA-Ib

tetramers to identify the maternal leukocytes that express receptors that bind BoLA-Ib
proteins.
Development of an enzyme-linked immunosorbent assay (ELISA) to measure
secreted MHC-Ib proteins in embryo and trophoblast culture supernatants and cattle
serum is important because secreted MHC-Ib proteins may be a biomarker for fetal
health. Once the importance of class Ib proteins in maintaining pregnancy has been
established, these proteins may offer a tool for preventing immune-mediated abortions in
naturally bred and cloned cattle.
Identification of the BoLA-Ib peptide motifs will facilitate BoLA-Ib tetramer
production. The BoLA-Ib tetramers can be used to identify and sort lymphocytes that
react with cattle MHC-Ib proteins so that their inhibitory and activating receptors can be
characterized.
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CHAPTER 2
EXPRESSION OF BOVINE CLASSICAL (BoLA-Ia) AND NON-CLASSICAL
(BoLA-Ib) CLASS I PROTEINS IN MOUSE P815 AND HUMAN K562 CELLS

Abstract
During the third trimester of pregnancy in cattle, interplacentomal trophoblast
cells express both classical (BoLA-Ia) and non-classical (BoLA-Ib) MHC class I
proteins. To investigate whether these proteins are expressed as surface or secreted
proteins, we cloned protein-coding DNAs in the pcDNA 3.1 mammalian expression
vector and sequenced the inserts to identify plasmids to transfect murine P815 and human
K562 (MHC null) cultured cells. Stably transfected P815 and K562 cell lines were
stained with H1A and W6/32 antibodies, respectively, to detect expression of the proteins
by flow cytometry. We identified two bovine classical (N*01701 and N*01802) and three
non-classical (NC1*00501, NC3*00101, and NC4*00201) proteins on the cell surface.
Other non-classical proteins (NC1*00401 and NC2*00102), which may be released or
secreted by cells into their surrounding extracellular spaces (soluble or secreted proteins),
do not exhibit cell surface expression. The surface expressing cells were sorted and
enriched. Both classical and non-classical proteins were precipitated from the cell culture
supernatant using ammonium sulfate. The cell lines with surface expressing BoLA-Ia and
BoLA-Ib proteins shed and/or released more MHC-I proteins into the culture
supernatants than unsorted non-surface expressing cell lines. Transfected cells were lysed
and histidine tagged proteins were purified using nickel affinity column chromatography.
Western blot analysis with an anti-V5 antibidy demonstrated the presence of MHC-I
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heavy chains in all of the transfected cell lines. These data confirm that bovine class Ib
molecules NC1*00501, NC3*00101, and NC4*00201 are expressed as surface isoforms.

Introduction
The MHC, the genetic region that encodes the proteins responsible for tissue graft
compatibility [21], encodes MHC class I (MHC-I) and MHC class II (MHC-II)
glycoproteins. There are two subclasses of MHC-I proteins. MHC-Ia proteins are
membrane-bound isoforms that are expressed in all nucleated cells of the body and
present intracellular pathogen-derived peptides or the animal’s own peptides on the cell
surface for immune recognition by CD8 T cells. With the discovery of HLA-G [12],
another category of MHC-I proteins referred, non-classical class I (MHC-Ib), was
recognized. MHC-Ib molecules are less polymorphic, possess specific molecular motifs
in their transmembrane domains and contain premature stop codons. These features make
MHC-Ib proteins important immunomodulatory molecules which may induce
immunotolerance during pregnancy. MHC-II proteins are expressed only on professional
antigen presenting cells (APCs) which present extracellular pathogen-derived peptides on
the cell surface for recognition by CD4 T cells.
An allogeneic transplant is a tissue graft from a genetically distinct member of the
same species. A fetus carrying half of its genome from the father is a semi-allogeneic
tissue inside the uterus, yet it circumvents the maternal immune system. Many studies
performed on humans, mice, and non-human primates reveal that both fetal and maternal
mechanisms contribute to the immunological tolerance of the mother to the fetus.
Placental lactogen, progesterone, prostaglandins and other immunomodulatory hormones
as well as chemokines synthesized by uterine cells, including T-regulatory cells and
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trophoblast cells, contribute to tolerance [17, 19, 38]. Non-classical class I molecules
produced by fetal trophoblast cells interact with inhibitory receptors expressed by Tlymphocytes and natural killer (NK) cells to inhibit these immune cells, thus protecting
the conceptus from maternal immune attack [1, 3, 11, 12, 17, 19, 23, 32]. The human
class Ib molecule HLA-G interacts with leukocyte inhibitory receptors such as leukocyte
immunoglobulin-like receptors 1 (LILR1) and LILR2 to induce immunosuppression [6,
19, 36]. HLA-G also upregulates expression of ILT2, ILT3, ILT4 and KIR2DL4 in
APCs, NK cells and T cells, which protects the HLA-G expressing tissues from immune
cell attack [26]. Qa-2, a mouse class Ib molecule and functional homolog of HLA-G,
controls the rate of cleavage and survival of mouse preimplantation embryos [6].
Alternative splicing is a mechanism for generating protein diversity in nonclassical major histocompatibility complex class I (MHC-Ib) molecules. Alternative
splicing produces membrane and soluble isoforms. In humans, differential mRNA
splicing of HLA-G results in synthesis of membrane isoforms, HLA-G1, -G2, and -G3
and soluble isoforms, HLA-G5 and –G6 [12, 19]. Similarly, murine Qa-2 encodes two
soluble isoforms, S1 Qa-2 and S2 Qa-2 [6], mamu-AG in rhesus monkeys encodes
membrane-bound isoforms Mamu-AG1, Mamu-AG2 and Mamu-AG3 [4], and Paan-AG
in baboons encodes four membrane isoforms, Paan-AG1, -AG2, -AG3 and -AG4, and a
soluble isoform, sPaan-AG1 [22]. Alternatively spliced variants of bovine class Ib
protein, BoLA-NC1 have also been found (Davies unpublished). However, splice
variants of BoLA-NC2, -NC3, and -NC4 have yet to be positively confirmed. This is the
first study to investigate the surface expression and/or secretion of BoLA-Ib proteins.
Here we report that the bovine class Ib molecules NC1*00501, NC3*00101, and
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NC4*00201 are expressed as cell surface proteins. However, membrane expression of the
bovine class Ib proteins NC1*00401 and NC2*00102 was not detected.
Most mammalian trophoblastic cells do not express polymorphic, classical, MHCI molecules [10, 18]. However, cattle interplacentomal and arcade trophoblast cells
normally express BoLA-Ia molecules during the third trimester of pregnancy [9]. MHCIa expression during the last trimester triggers the release of the placenta during
parturition [8, 16]. Interplacentomal trophoblast cells from late pregnancy expressed
classical (BoLA-Ia) and non-classical (BoLA-Ib) genes at varying levels depending on
the specific MHC class I haplotypes carried by the conceptus [7]. Comparatively,
trophoblast cells expressed more MHC class I transcripts encoded at non-classical loci
than peripheral blood mononuclear cells (PBMC). However, all of the classical genes
expressed in PBMC were also expressed in trophoblast cells.
We propose that bovine trophoblast cells express cell surface and secreted nonclassical MHC-I proteins. To investigate this hypothesis, we used the murine
mastocytoma cell line P815 (ATCC TIB-64) and the human MHC-null cell line K562
(ATCC CCL-243) to express cattle class I proteins. Cells were transfected with bovine
transgenes encoding classical and non-classical class I proteins. Post-transfection analysis
of cell surface expression was performed by flow cytometry. Secreted proteins in culture
supernatants were precipitated by ammonium sulfate precipitation and then detected
using Western blots.
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Materials and Methods
Samples
Full-length MHC-I cDNA was reverse transcribed from interplacentomal
trophoblast-RNA, cloned in the pCR II TOPO vector (Invitrogen), and stored at -80°C as
part of a previous study [7]. These were the initial samples used in the current study.

Subcloning of Classical and Non-Classical MHC Class I Genes
We amplified classical (N*01802 and N*01701) and non-classical (NC1*00401,
NC1*00501, NC2*00102, NC3*00101 and NC4*00201) class I alleles from the AH11
haplotype using Platinum Pfx DNA polymerase (Invitrogen) and subcloned them into the
pcDNA3.1 One Directional V5-His mammalian expression vector (Invitrogen) to express
the protein with a 3’ 6x His tag and a V5 epitope. Fifty µL PCR reactions were prepared
by adding 1 U Taq DNA Polymerase (proofreading), 0.8 µM of each primer (listed
below), 2.0 mM MgSO4, 0.2 mM dNTPs, 1X optimized PCR buffer, and 2 µL of the
diluted (1:1000) cDNA from the pCR II TOPO clone. PCR amplification was carried out
using an Eppendorf Master cycler (Brinkmann) with the following parameters: 1 min 30
sec at 94ºC; 25 cycles of 30 sec at 94ºC, 15 sec at 60ºC and 90 sec at 68ºC; 10 min at
68ºC; hold at 4ºC. PCR products were purified with the QIAquick PCR Purification Kit
(Qiagen) and product size was confirmed using 1% agarose gel electrophoresis. Purified
DNA was ligated into the pcDNA 3.1 expression vector for 5 min at room temperature,
transformed into TOP10F’ One Shot Competent Escherichia coli (Invitrogen), and plated
on LB agar containing 100 µg/mL ampicillin. There was no blue/white screening.
Consequently, insert size in isolated colonies was checked by PCR amplification of lysed
bacteria with T-7 forward and BGH reverse sequencing primers, which bind to sites
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within the vector, followed by agarose gel electrophoresis. Only clones with inserts of the
expected size were considered for further evaluation. One forward and two reverse
amplification primers were used:
Forward primer (BoC1FP-E1B)

ACCATGGGGCCGCGAACCCTC

Reverse primer (BoC1RP-3’A)

GATGAAGCATCACTCAGTCCCC

Reverse primer (BoC1RP-E7A)

TTTAGGAACCGTGAGAGACACATC

By using two different reverse primers, clones with the normal stop codon
(reverse primer BoC1RP-3’A) and clones expressing a 3’ 6x histidine tag and a V5
epitope (reverse primer BoC1RP-E7A) were produced.

Sequencing of Subclones
Correct size subclones were sequenced using T-7 forward and BGH reverse
sequencing primers and subclones with full-size insert were selected for expression. For
all the alleles, clones from multiple cell preparations were sequenced. Plasmids were
purified using a QIAprep spin Miniprep Kit (Qiagen), and sequenced in both directions
using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) and ABI
Prism 3100 DNA Analyzer (Applied Biosystems). Sequence analysis was done using
Lasergene SeqMan II software (DNASTAR, Inc.) to trim vector sequences and
generate MHC class I consensus sequences. The ClustalW method of Lasergene MegAlign software (DNASTAR, Inc.) was used to align sequences.

Cell Lines and Transfection
P815 cells are mast cells derived from a DBA/2 strain-mouse (Mus musculus)
with a mastocytoma. The majority of these cells grow in suspension with some (<5%)
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adherent cells. Cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM)
(Caisson Laboratories) with 10% bovine calf serum (Hyclone), 2mM L-glutamine
(Hyclone) and penicillin 100 units/ml and streptomycin 100 µg/ml (Hyclone) at 37°C,
5% CO2.
The K562 cell line (CCL-243) is an MHC null cell line originated from a person
with chronic myelogenous leukemia. These cells grow in suspension and were grown in
Iscove’s Modified Dulbecco’s Medium (IMDM) (Fisher Scientific) supplemented with
10% bovine calf serum, 100 units/ml Penicillin and 100 µg/ml Streptomycin (Hyclone) at
37°C, 5% CO2. Both cell lines were obtained from American Type Culture Collection
(ATCC, USA).
Cells were transfected with subclones of either a classical or non-classical MHC
class I gene in the pcDNA3.1 vector using Lipofectamine 2000 (Invitrogen) transfection
reagent. Untransfected cells were used as a negative control. Beta-galactosidase supplied
with the vector kit was expressed in P815 cells as a transfection positive control. Briefly,
plasmids from the correct subclones were isolated using a QIA plasmid Mini Prep kit
(Qiagen). Plasmids carrying cDNA for N*01802, N*01701, NC1*00401, NC1*00501,
NC2*00102, NC3*00101 and NC4*00201 were used. Cells were washed 1x with
DMEM or IMDM (without serum or antibiotics) and resuspended at 1x106 cells/ml. For
the transfections, 2 ml of cells (2x106 cells) were plated per well in a 6-well tissue culture
plate and incubated at 37°C, 5% CO2.. Four micrograms of plasmid DNA was diluted to
250 µl in DMEM and mixed gently. Lipofectamine was mixed gently before use, and
then 10 µl was diluted in 250 µl of DMEM or IMDM and incubated for 5 min at room
temperature. The diluted DNA was combined with diluted Lipofectamine (total volume =
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500 µl) and mixed gently. The mixture was incubated for 20 min at room temperature.
After the 20 min incubation, 500 µl of the complex (plasmid + Lipofectamine) was added
to each well containing cells and mixed gently. Cells were incubated at 37°C, 5% CO2 for
3 hours and then 5 ml of DMEM or IMDM with 10% bovine calf serum was added to
each well. Transfected cells were incubated for 24 to 48 hours prior to selection of stable
transfectants by addition of G418 (Invivogen) antibiotic (500 µg/ ml). After two weeks in
selective media the transfectants were screened by flow cytometry.

Flow Cytometry
The following monoclonal antibodies were used in the analysis. The anti-human
MHC-I monoclonal antibody W6/32, which recognizes MHC class I heavy chains
associated with human or bovine beta-2-microglobulin (β2m), was used as a negative
control for MHC-null K562 cells and as a positive control for mouse P815 cells because
they express mouse class I proteins that bind bovine β2m present in the culture medium.
ColiS205D1 (IgG2a), which is specific for Escherichia coli antigen, was used as an
isotype negative control. The anti-bovine MHC class I monoclonal antibody H1A was
used to detect bovine MHC class I heavy chains. Other anti-bovine MHC class I
antibodies that were also used included: H6A, H11A, H58A, PT85-A, and IL-A88. All of
the monoclonal antibodies were obtained from the Monoclonal Antibody Center at
Washington State University, Pullman, WA. Fluorescein isothiocyanate (FITC)
conjugated anti-mouse IgG antibody (KPL) was used as a secondary antibody. For
staining, cells were resuspended in fluorescence buffer (FB; PBS with 0.1% Sodium
Azide, 1% bovine serum albumin) and incubated with primary antibody (15 µg/ml) for
15 min. Cells were washed twice with FB and then incubated with secondary antibody
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for 15 min. All incubations were performed at 4°C. Cells were washed twice and fixed in
PBS with 1% formaldehyde or paraformaldehyde. One million cells were stained for each
sample. Cells were analyzed using a Becton-Dickinson FACSAria II fluorescence
activated cell sorter (FACS) equipped with FACS Diva software. The FACSAria II was
also used to sort the transfected cells to enrich the high expressing cells.

Western Blot
The high sensitivity Western Breeze Chemiluminiscence Kit (Invitrogen) with
Alkaline Phosphatase (AP) conjugated anti-mouse secondary antibody was used to
perform Western blots. Ten microliters of cell lysate or purified dialysate was added to 5
µl 4x LDS sample buffer (Invitrogen) and 5 µl deionized water. Twenty microliters of
each sample was heated at 70°C for 10 min and 15 µl was loaded on a NuPAGE® Novex
4-12% Bis-Tris Gel (Invitrogen). After 30 min of electrophoresis at a constant voltage of
200V, proteins were transferred to a polyvinylidene difluoride (PVDF) membrane
(Invitrogen) using a XCell SureLock® Mini-Cell and XCell II™ Blot Module Kit
(Invitrogen). Transfer was performed for 80 min at a constant voltage of 30 Volts.
Membranes were blocked with blocking buffer provided with the Western Breeze Kit and
stained with anti-V5 antibody or AP conjugated anti-V5 antibody (Invitrogen) as per the
instructions provided by the manufacturer. Chemiluminiscence was detected by exposing
Blue X-ray film (ISC Bioexpress) to the blots for different exposure times.
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Purification of Recombinant Histidine Tagged Proteins
Transfected P815 and K562 cells were grown in T75 cell culture flasks (Corning)
to harvest ~100 x 106 cells. Cells were harvested by centrifuging at 1500 RPM for 10 min
at RT. Cells were washed in ice cold PBS, pH 7.2 and lysed in lysis buffer (50 mM Tris,
pH 7.8, 150 mM NaCl, 1% Nonidet P-40). Lysis was performed by incubating the cells
for 1 hour at 4°C. One micromole protease inhibitor cocktail (Sigma) for mammalian cell
extracts and 1mM PMSF (Phenyl Methane Sulfonyl Fluoride) were also added to the
suspension. Cells were centrifuged at 10,000 RPM for 10 min at 4°C and the supernatant
was filtered using 0.2 µM filters and stored in sterile tubes at -20°C until used for
purification.
HisGraviTrap Columns (GE Healthcare) were used to purify histidine-tagged
proteins. The manufacturer’s recommended purification procedure was followed. After
loading lysate to the column, it was washed 4 times with wash buffer with 40 mM
imidazole. Elution was performed with elution buffer containing 500 mM imidazole.
Purified eluates were stored at -20°C. Eluates with specific strong bands were pooled and
dialyzed against phosphate buffer solution (20 mM Sodium Phosphate, 500 mM NaCl,
pH 7.4) using 20 kD molecular weight cut-off (MWCO) Slide-A-Dialysis cassettes
(Pierce). To prevent precipitation and to maximize the stability of the protein, 50 mM
charged amino acids L-Arg and L-Glu were added to all purification buffers and dialysis
buffers [15]. Dialysates were centrifuged at maximum speed for 10 min at 4°C and the
supernatant was recovered in a fresh tube. The dialysates were concentrated using
vivaspin-20 concentrators with 30 KD MWCO membranes (VIVASPIN). Concentrations
of dialysates were measured using a BCA protein assay kit (Thermo Scientific).
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Ammonium Sulfate Precipitation
Thirty percent ammonium sulfate (AS) was used to precipitate proteins in the
culture supernatants (exhausted media) from the cultured transfected cells. The required
quantity of ammonium sulfate was calculated using the EnCor Biotechnology Inc.
webpage (http://www.encorbio.com/protocols/AM-SO4.htm). Salt was added slowly
while stirring the supernatant. Precipitation was performed at 4°C for 1 hour. The
suspension was centrifuged at 10,000 x g for 10 min at 4°C to pellet the insoluble
precipitated material. The supernatant was poured off and the pellet was dissolved in a
mixture of 50% phosphate buffer with 50 mM L-Arg and L-Glu, pH 7.2 and 50% DMSO.

Results
Subcloning and Sequencing Analysis
Most of the subclones had inserts with the correct sequences in the correct
orientation and contained the C-terminal 6x Histidine tag and V5 epitope in-frame. The
following alleles from the AH11 haplotype were expressed in the two cell lines:
N*01701, N*01802, N*01701, NC1*00401, NC1*00501, NC2*00102, NC3*00101 and
NC4*00201.

Evaluation of Cell Surface Expression by Flow Cytometry
In order to determine which bovine class Ib proteins were expressed on the cell
surface, selected and stably transfected cell lines were stained and analyzed using flow
cytometry. W6/32, which reacts with the MHC class I heavy chains associated with β2m,
was positive on untransfected P815 cells as these cells express mouse class I proteins. On
the other hand, W6/32 antibody was negative on untransfected K562 cells because this
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cell line does not express MHC antigens. ColiS205D1 showed no reactivity with any of
the cell lines and served as a negative control antibody for both the P815 and K562 cells.
Monoclonal antibody H1A recognizes bovine class I heavy chains. H1A antibody reacted
with P815 cells expressing N*01701, N*01802, NC1*00501 or NC3*00101 proteins,
whereas it did not recognize P815 cells expressing the other bovine non-classical class I
proteins (Figure 2-1). The same pattern was seen with the H6A, H11A, H58A, PT-85A
and IL-A88 antibodies.
K562 cells expressing N*01701, N*01802, NC1*00501, NC3*00101 and
NC4*00201 were positive with W6/32 (Figure 2-2). H1A, H6A, H11A, H58A, PT-85A,
IL-A88 were also positive on K562 cells transfected with these proteins. Twenty-four
hour post-transfection expression was <20% compared to untransfected cells which
increased to ~40% after selection with G418 for 2 weeks. Therefore, we used FACS to
sort the positive stably transfected cells to enrich transgene expression. Sorting of
transfected P815 cells was done using cells stained with the H1A antibody. Transfected
K562 cells were sorted on the basis of staining with W6/32. Sorted cells were cultured in
appropriate media for one week and rechecked on the flow cytometer to determine the
post-sort MHC-I expression level. N*01701, N*01802, NC1*00501, NC3*00101, and
NC4*00201 positive cell lines were enriched to more than 90% expression of the proteins
after sorting. Due to the lack of surface expression of the NC1*00401 and NC2*00102
non-classical class I proteins, we were not able to sort the cell lines expressing these
transgenes (Figures 2-1 and 2-2). The results of the class I monoclonal antibody
screening of the transfected cell lines using flow cytometry are summarized in Tables 2-1
and 2-2.
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Fig. 2-1: Flow cytometric analysis of murine P815 cells transfected with cattle MHC
class Ia and class Ib transgenes. ColiS205D1 and W6/32 were used were used as negative
and positive controls, respectively. Three anti-bovine MHC-I monoclonal antibodies
were used: H1A, IL-A88, and PT-85A. As shown, the BoLA-NC1*00401, BoLANC2*00102, and BoLA-NC4*00201 class Ib proteins did not exhibit surface expression
on P815 cells. On the other hand, BoLA-Ia proteins, N*01701 and N*01802, and BoLAIb proteins NC1*00501 and NC3*00101 proteins were expressed on the cell membrane
of transfected P815 cells.
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We noticed that the antibodies tested varied in their affinity for different proteins. In
addition, there was considerable variation in the level of expression of the bovine MHC-I
proteins. The classical N*01701 protein was expressed at the lowest level and the nonclassical NC3*00101 protein was expressed at highest level in both P815 and K562 cells.
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Fig. 2-2: Flow cytometric analysis of BoLA-Ia and -Ib expression on transfected human
MHC-null K562 cells. Untransfected cells served as a negative control. W6/32, H1A,
H6A, H11A, and PT-85A antibodies were used to detect bovine class I proteins. As
shown, BoLA-NC1*00401 and BoLA-NC2*00102 class Ib proteins did not exhibit
surface expression on K562 cells. BoLA-Ia proteins, N*01701 and N*01802, and BoLAIb proteins NC1*00501, NC3*00101, and NC4*00201 proteins were expressed on the
surface of transfected K562 cells.
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Detection of Protein Expression by Western Blotting
To confirm that the transgenes were translated in the host cells, we performed
Western blotting of the crude cell lysates using an anti-V5 antibody (Invitrogen), which
recognizes the V5 epitope. We also tested an antibody directed against the C-terminal His
tag (Invitrogen) but this antibody did not work. A cell line transfected with βgalactosidase was used as a positive control and had a 120 kD band as expected. A lysate
from untransfected cells was used as a negative control. All of the bovine class Ia and
class Ib proteins were identified in lysates from transfected cells with the anti-V5
antibody. The bands were all approximately 45 kD in size as determined with the Magic
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Table 2-1 Reactivity pattern of monoclonal antibodies on P815 cells transfected with
cattle MHC-I genes
Antibody

Untransfected
P815 Cells

Transfected P815 Cells
N*01701

N*01802

NC1*00401

NC1*00501

NC2*00102

NC3*00101

NC4*00201

ColiS205D1

-

-

-

-

-

-

-

-

W6/32

++++

++++

++++

++++

++++

++++

++++

++++

IL-A88

-

+++

++++

-

++++

-

++++

-

H1A

-

+++

++++

-

++++

-

++++

-

H6A

-

++

++++

-

+++

-

++++

-

H11A

-

++

++++

-

+++

-

++++

-

H58A

-

+++

++++

-

+++

-

++++

-

PT-85A

-

+++

++++

-

++++

-

++

-

Table 2-2 Reactivity pattern of monoclonal antibodies on K562 cells transfected
with cattle MHC-I genes
Antibody

Untransfected
K562 Cells

Transfected K562 Cells

W6/32

-

N*0170
1
++++

N*01802

NC1*00401

NC1*00501

NC2*00102

NC3*00101

NC4*00201

++++

-

++++

-

++++

++

H1A

-

+++

++++

-

+++

-

++++

++

H6A

-

+++

++

-

++

-

++++

++

H11A

-

+++

++++

-

++

-

++++

++

H58A

-

+++

++++

-

++

-

++++

++

PT-85A

-

+++

++++

-

+++

-

++

+
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Mark (Invitrogen) ladder. The NC1*00401 protein, which has a complete deletion of the
transmembrane domain, was slightly smaller than the other MHC class I proteins.
Sometimes there were non-specific protein bands seen in the crude lysates of the
transfected cells, but these bands disappeared after purification of the proteins with His
GraviTrap Columns (GE Healthcare; Figures 2-3 and 2-4).

Fig 2-3: Purified proteins from transfected murine P815 cells

Fig 2-4: Purified proteins from transfected human MHC null K562 cells
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Assessment of Protein Secretion by Ammonium Sulfate Precipitation
Ammonium sulfate precipitation was performed on exhausted media from all of
the cultured cell lines. Precipitated protein pellets were dissolved in 50% phosphate
buffer with L-Arg and L-Glu amino acids and 50% DMSO and processed to run on
Western blots. MHC class I proteins in the culture supernatants were detected by Western
blotting with anti-V5 antibody (Figures 2-5 and 2-6). Strong bands were present for all of
the surface expressed MHC class I proteins: N*01701, N*01802, NC3*00101, and
NC4*00201 (only in K562 cells). This suggests that the class I proteins are being shed
from the cell membrane at a significant rate. There was a clear but fairly weak band for
NC1*00401, which lacks the transmembrane domain, in the supernatant from K562 cells,
suggesting that this may be a secreted isoform. The NC2*00102 protein apparently
remained trapped inside the cells as it was not detected in the culture supernatants.

Fig 2-5: Ammonium sulfate-precipitated proteins from transfected murine P815 cellculture supernatants
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Fig 2-6: Precipitated proteins from transfected human K562 cell-culture supernatants

Discussion
We performed transfection experiments to identify proteins encoded by two
classical and four non-classical genes. Our experiments showed that the two classical
isoforms, N*01701 and N*01802, and the non-classical isoforms, NC1*00501,
NC3*00101, and NC4*00201, are surface or membrane proteins expressed on the cell
surface. Immunoblotting experiments with proteins precipitated from culture supernatants
showed that these proteins are also shed or released from the cell membrane.
NC1*00401, which lacks a transmembrane domain, was secreted at a noticeable but low
level by transfected K562. The NC2*00102 protein was not expressed on the cell
membrane or secreted by either of the transfected cell lines that were tested. Detection of
the MHC class I proteins by flow cytometry and Western blots provides clear evidence
that the classical and non-classical MHC class I transcripts isolated from third-trimester
interplacentomal trophoblast cells are translated into proteins.
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We do not have monoclonal antibodies that are specific for the bovine nonclassical class I proteins. We are currently in progress to produce monoclonal antibodies
to NC3*00101 protein by direct immunization of mice with transfected cell lines. We
could not detect surface expression of NC1*00401 and NC2*00102 with W6/32, H1A or
the other antibodies that were tested. A previous transfection study done with
NC2*00101 showed no surface expression with ILA-88 [13]. NC1*00401 does not have
a transmembrane domain [7], hence we did not expect this protein to be expressed on the
cell surface. NC4*00201, which was not expressed on the surface of P815 cells, showed
surface expression on K562 cells. It is likely that human β2m can associate with this
protein thereby allowing peptide binding and cell surface expression, while murine β2m
does not form a functional heterodimer with this bovine MHC class I heavy chain.
Expression of membrane bound and secreted forms of BoLA-Ib proteins is
important because these proteins may inhibit maternal leukocytes by interacting with
inhibitory receptors expressed by the leukocytes. Membrane bound and secreted class Ib
proteins, such as HLA-E, -F, and -G in humans, Qa-2 in mice, and Mamu-E in rhesus
monkeys, interact with receptors such as LILRB1, LILRB2, KIR2DL4 and
CD94/NKG2A expressed by maternal leukocytes and inhibit their cell-lysis properties [1,
2, 6, 14, 17, 19, 20]. Membrane bound HLA-G isoforms as well as soluble isoforms play
an immunosuppressive role in human pregnancy. Membrane isoforms induce suppression
of CD4+ T cells and NK cells [25, 31]. It also has been reported that T cells and NK cells
are rendered immunosuppressive by the transfer of membrane patches containing HLA-G
from APCs or tumor cells [5, 31]. The soluble HLA-G1 isoform induces maternal fetal
tolerance by inducing apoptosis of activated CD8 T cells [24, 37] and down-regulating
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CD4 T cell proliferation [29]. It has been reported that sHLA-G inhibits NK cellmediated cytotoxicity [30, 32, 33, 35]. It is possible, that secreted or shed cattle class Ib
molecules act as soluble immunosuppressive factors during pregnancy.
There is nothing known about the role of class Ib proteins in cattle. The surface
expressed BoLA-Ib proteins, secreted NC1*00401, and even NC2*00102 may interact
with inhibitory receptors expressed by maternal leukocytes and provide inhibitory
signals. Consequently, it is important to conduct studies to identify the leukocytes and
inhibitory receptors that interact with BoLA-Ib proteins. To identify bovine class Ib
glycoproteins in trophoblast cell culture supernatants, there is a need for monoclonal
antibodies to these proteins.
We were not able to see NC2*00102 protein on the cell surface. In humans, HLAE does not bind with the peptides derived from intracellular proteins. Instead they bind
with peptides derived from other HLA class I signal sequences as required for cell
surface expression [3, 27, 28, 34]. It is possible that NC2*00101 is a homologue of
human HLA-E and requires a specific peptide or leader peptide for its cell surface
expression.
In summary, we have identified that cattle class Ia proteins, N*01701 and
N801802, and class Ib proteins, NC1*00501, NC3*00101, and NC4*00201, are the
surface expressing proteins whereas, NC1*00401 and NC2*00102 proteins, are not
expressed on the cell-surface.
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CHAPTER 3
SCALE-UP OF BoLA-NC3*00101 PROTEIN EXPRESSION IN MOUSE P815
CELLS USING A PITCHED-BLADE

Abstract
In an attempt to express and isolate BoLA-NC3*00101, a bovine non-classical
MHC (Major Histocompatibility Complex) class I protein (class Ib), the mouse
mastocytoma cell line P815 was transfected with the NC3*00101 transgene. The
transfected cells were checked for expression by flow cytometry and positive stable
transfectants were sorted using a fluorescence activated cell sorter (FACS). A large
amount of purified protein is required to immunize and boost the host for several months
to produce monoclonal antibodies. To avoid the use of a large number of cell culture
flasks and shorten the time to obtain a sufficient quantity of protein, stably transfected,
BoLA-NC3*00101 expressing cells were grown in a pitch-blade bioreactor. One week of
culturing in a pitched-blade bioreactor yielded a large cell mass, which was used to
isolate and purify the protein.

Introduction
Transplantation antigens were discovered as molecules responsible for acceptance
or rejection of tissue grafts in mice [1]. The acceptance or rejection depends on the
degree of similarity among these antigens on the cells of the donor and recipient animals.
The genetic region encoding the most important proteins for tissue graft compatibility is
called the major histocompatibility complex (MHC). The MHC encodes two types of
highly polymorphic cell surface glycoproteins, the MHC class I (MHC-I) and MHC class
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II (MHC-II) proteins, which present peptide antigens to T lymphocytes. MHC-I proteins
have two subsets, classical (MHC-Ia) and non-classical (MHC-Ib). MHC-Ia proteins are
expressed on all nucleated cells in the mammalian body. Consequently, any tissue graft
will express class Ia proteins and thus the recipient will react to the graft. In addition,
class Ia proteins are extremely polymorphic or highly variable in the population,
therefore tissue graft donor-recipient pairs are rarely MHC-matched [2]. MHC-Ia proteins
are usually expressed as membrane bound isoforms and interact directly with the T cell
receptor. In contrast, class Ib proteins are expressed in specific tissues or organs and their
expression may or may not be conditional. They are less polymorphic and have few
variants; therefore they do not induce a transplant rejection. MHC-Ib proteins are
expressed as membrane-bound and soluble isoforms.
A tissue graft from another member of the same species is known as an allogeneic
transplant. A fetus is an allogeneic tissue that resides inside the maternal uterus during
pregnancy. The MHC genetic region of cattle is known as the bovine leukocyte antigen
(BoLA) complex. Bovine trophoblast cells (the cells that form the outer membrane of the
placenta and attach the embryo to the uterine wall) express four non-classical MHC class
I genes, BoLA-NC1, -NC2, -NC3 and -NC4 [3]. These class Ib proteins are believed to
play an important role in protecting the fetal tissue graft from hostile maternal immune
attack throughout pregnancy. Both class Ia and Ib proteins help protect cells against
attack by natural killer (NK) cells. MHC class I deficient cells are usually susceptible to
NK cell-attack and macrophage killing [4].
To study whether the bovine non-classical class I proteins are expressed as cell
surface and/or soluble isoforms, P815 (mouse mastocytoma) cells were transfected with
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the transgenes encoding these proteins. The mouse P815 cell line is a transfection
competent cell line that has been used for expressing a variety of MHC class I proteins,
including HLA-B27 [5]. Transfected P815 cell lines have been used as immunogens to
immunize mice to produce monoclonal antibodies against HLA-B27 and other HLA-B
antigens [5]. In other studies P815 cells have been transfected with equine [6, 7] and
bovine MHC class I protein-encoding transgenes [3, 11].
Transfection studies revealed that BoLA-NC3*00101, was expressed on the cell
surface whereas the other three bovine MHC-Ib proteins (BoLA-NC1*00401,
NC2*00102 and NC4*00201) were not expressed as cell-surface isoforms as determined
with flow-cytometric analysis of transfected P815 cells (Parasar et al. in preparation).
The other three MHC-Ib proteins are probably expressed as secreted isoforms. Our
objective was to produce monoclonal antibodies against bovine MHC-Ib proteins and
utilize the antibodies to detect soluble MHC-Ib proteins in trophoblast culture
supernatants and serum from pregnant cows. Since NC3*00101 protein is expressed on
the cell surface as a membrane bound protein, it was possible to sort the positive and
stable NC3*00101 transfectants using FACS. Scale-up in a bioreactor was used to
achieve higher cell mass and isolate more protein in shorter time than in issue culture
flasks.
To date there is no report of any monoclonal antibody that can differentiate the
bovine NC3*00101 protein from other bovine MHC-I proteins. Availability of an
NC3*00101 specific monoclonal antibody will greatly assist in determining the level of
NC3*00101 protein expressed on the surface of trophoblast cells at different stages of
pregnancy and the amount of protein secreted in trophoblast cultures. In order to isolate a
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sufficient amount of NC3*00101 protein to immunize mice for antibody production, a
high number of P815 cells expressing bovine NC3*00101 protein was required. A
bioreactor is an efficient, well-established, specialized, simulated biologically active
environment. Growing cells in a bioreactor yields a far greater cell mass in a shorter time
without affecting the integrity and quality of the cells or their products. Pitched-blade
impellers have flat blades that are set at a 45° angle so that they provide simultaneous
radial and axial flow. Combined radial and axial flow produces better mixing and
promotes a high oxygen transfer rate. Animal and plant cells often have low resistance to
shear [9]. Pitched-blade impellers are low shear blades that cause less cell damage and
provide gentle and smooth mixing of the cells in culture. This type of impeller is widely
used with mammalian, insect and other shear sensitive cell-lines growing in suspension
[10]. Because of these characteristics, we decided to grow transfected P815 cells
expressing NC3*00101 in a pitched-blade bioreactor.

Materials and Methods
Cell Line
The P815 cell line is a mast cell line derived from a DBA/2 strain-mouse (Mus
musculus) with a mastocytoma. The majority of these cells grow in suspension with some
(<5%) adherent cells. Cells were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) with 10% bovine calf serum at 37°C and 5% CO2. The cell line was obtained
from American Type Culture Collection (ATCC, USA).
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Transfection and FACS Sorting of Stable NC3*00101 Transfectants
The BoLA-NC3*00101 coding sequence was amplified from complementary
DNA (cDNA) using specific primers (Forward primer
CACCATGGGGCCGCGAACCCTC and reverse primer
GATGAAGCATCACTCAGTCCCC). The pcDNA3.1 directional TOPO expression
vector (Invitrogen) was used for cloning the cDNA and expressing the protein in
mammalian P815 cells. Positive clones were sequenced and full-length NC3*00101 clone
was selected for transfection. Plasmid was purified using a QIA plasmid Mini Prep kit
(Qiagen). Lipofectamine 2000 (Invitrogen) was used to transfect P815 cells with the
pcDNA3.1 plasmid. This vector allows for expression of a specific protein with a V5
epitope and a C-terminal polyhistidine (His-His-His-His-His-His) fusion tag. The V5
epitope permits easy detection of recombinant protein by Western blot with anti-V5
antibody and the polyhistidine tag allows rapid purification on nickel-chelating resin,
which binds His-tagged proteins.
To transfect, the cells, 2 x 106 cells (1x 106 cells/ml of DMEM) were plated per
well in a 6-well tissue culture plate and incubated at 37°C with 5% CO2. Four µg of
plasmid DNA was diluted to 250 µl in DMEM and mixed gently. Lipofectamine was
mixed gently before use, and then 10 µl was diluted in 250 µl of DMEM and incubated
for 5 min at room temperature. The diluted plasmid DNA was combined with diluted
Lipofectamine (total volume = 500 µl), mixed gently and incubated for 20 min at room
temperature. An aliquot of 500 µl of plasmid and Lipofectamine was added to each well
containing cells and medium and mixed gently. Cells were incubated at 37°C, 5% CO2
for 3 hours, then 5 ml of DMEM with 10% bovine calf serum was added to each well.
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Transfected cells were incubated for 24 to 48 hours prior to addition of G418 antibiotic
(500 µg/ml; Invivogen) to select for stable transfectants. After two weeks in selective
media the transfectants were screened using flow cytometry.
The flow cytometry staining procedure was as follows. One million cells were
resuspended in fluorescence buffer (FB) [Phosphate Buffered Saline (PBS) with 0.1%
sodium azide, 1% bovine serum albumin] and incubated with primary antibody for 15
min. The H1A monoclonal antibody was used for labeling the NC3*00101 protein and an
irrelevant antibody, ColiS169A, which does not recognize the mouse P815 cells or the
bovine class I protein, was used as a negative control. Both monoclonal antibodies were
obtained from the Monoclonal Antibody Center at Washington State University, Pullman,
WA. Cells were washed twice with FB and then incubated with a fluorescein labeled
anti-mouse IgG (Heavy+Light) secondary antibody for 15 min. All incubations were
performed at 4°C. Cells were washed twice and fixed in PBS with 1% formaldehyde.
Cells were analyzed using a BD Biosciences FACSAria II flow cytometer equipped with
Diva software for data acquisition and analysis.
Prior to culturing the cells in the bioreactor, Fluorescence Activated Cell Sorting
(FACS-sorting) was performed with the FACSAria II to isolate a subpopulation of cells
expressing a high level of NC3*00101 protein. The cells were stained with the H1A
monoclonal antibody as described above but were not fixed in fluorescence fixative. The
sorted high-expressing cells were grown in T75 flasks until they reached a sufficient
number to seed the bioreactor.
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Culturing of Sorted NC3*00101-Transfectants in the Pitch-Blade Bioreactor
Sorted NC3*00101 cells were grown in T-75 flasks at a seeding concentration of
1 x 106 cells/ml until a sufficient number of cells were obtained. Cells were harvested
from eight T-75 flasks by centrifugation at 1000 RPM (500 g) for 10 min at room
temperature. Cells were stained with Trypan Blue (0.4% solution) and enumerated with a
Countess Automated Cell Counter (Invitrogen). The cells used to seed the bioreactor had
a viability of ≥95%.
A New Brunswick Scientific Celligen®310 stirred tank bioreactor vessel with 5
liter capacity (3.5 L working volume) was used for culturing the cells. Because of the
shear sensitivity of the mouse P815 cells, a pitched-blade impeller was selected for this
experiment (Figure 3-1). The bioreactor vessel was installed on the control station. The
vessel was filled with PBS before autoclaving and the pH probe was calibrated before
vessel sterilization. The sterile assembly was taken to a laminar flow hood and the PBS
was replaced with 3.5 liters of sterile prewarmed (37°C) DMEM supplemented with 10%
bovine calf serum, 2 mM L-glutamine and 2 mM penicillin-streptomycin using a
peristaltic pump. The reactor was seeded with 2 x 105 cells/ ml and the dissolved oxygen
(DO) probe was calibrated. Cell viability was monitored by counting sample of cells
daily using a Countess Automated Cell Counter (Invitrogen). The BioFlo 310 cascades
were used to control DO and pH levels. After three days of cell growth the culture was
collected into sterile bottles and cells were harvested by centrifugation at 2000 g for 10
min at 4°C. The process parameters and cascade loops are shown below.
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Fig 3-1 Pitched-Blade Bioreactor

Process Parameters
Air
Temperature`
Gas Flo
Agitation
pH
Dissolved Oxygen (DO)

4-Gas mixture (Air, O2, CO2, N2)
37°C
0.5 slpm
35 rpm
7.2
50%

Cascade Loops
From

To

DO
pH

DO
pH

Start Set
Point
0.0
0

DO Start
Output %
50
25

End Set
Point
100%
100%

DO End
Output%
100
100

Purification of NC3*00101 Protein
Cells were kept on ice during lysis. One ml of 1X lysis buffer (50 mM Tris-HCl,
pH 7.4; 150 mM NaCl with 1 mM mammalian protease inhibitor cocktail (Sigma), 1 mM
PMSF) was added per 1 x 107 cells. Cells were incubated at 4°C for 1 hour with rotation.
The suspension was then centrifuged at 10,000 g for 15 min at 4°C to remove insoluble
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material and nuclei. The supernatant containing protein was collected in fresh tubes and
stored at -20°C until processed for protein purification.
His-GraviTrap Columns (GE Healthcare) were used to purify the histidine tagged
protein. After loading lysate on the column, it was washed 4 times with wash buffer with
40 mM imidazole. Elution was performed with elution buffer containing 500 mM
imidazole. Purified eluates were stored at -20°C. Eluates with specific bands on Western
blots were pooled and dialyzed against phosphate buffer solution (20 mM sodium
phosphate, 500 mM NaCl, pH 7.4) using 20 kilodalton (kD) MWCO Slide-A-Dialysis
cassettes (Pierce). To prevent precipitation and to maximize the stability of proteins 50
mM charged amino acids, L-arginine and L-glutamate were added to all the purification
buffers and dialysis buffers [8]. Dialysates were centrifuged at maximum speed for 10
min at 4°C and the supernatant was recovered in a fresh tube. The dialysates were
concentrated using Vivaspin-20 concentrators with 30 KD MWCO membranes
(Vivaproducts). The concentration of each fraction was measured using a BCA protein
assay kit (Thermo Scientific).

Western Blotting
Western blots were performed with a highly sensitive Western Breeze
Chemilluminiscence Kit (Invitrogen). Ten µl of NC3*00101 protein was mixed with 5 µl
LDS sample buffer (Invitrogen) and 5 µl deionized water and heated at 70°C for 10 min.
Fifteen µl of denatured protein was loaded in each lane of a NuPAGE® Novex 4-12%
Bis-Tris Gel (Invitrogen). After 30 min of electrophoresis at a constant voltage of 200 V,
proteins were transferred to a polyvinylidene difluoride (PVDF) membrane (Invitrogen)
using an XCell SureLock® Mini-Cell and XCell II™ Blot Module Kit (Invitrogen).
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Transfer was performed for 80 min at a constant voltage of 30 volts. Membranes were
blocked with blocking buffer provided with the Western Breeze Kit and stained with AP
conjugated anti-V5 antibody (Invitrogen) as per the instructions recommended by the
manufacturer. Blots were evaluated by exposure of Blue X-ray film (ISC Bioexpress) for
different exposure times.

Results
Flow Cytometric Analysis of Transfected Cells and Sorting
Less than 20% of newly transfected P815 cells expressed BoLA-NC3*00101
protein that could be detected by immunostaining and flow cytometry. Growth in G418
antibiotic was used to select stable transfectants. Following two weeks of selection
approximately 50% of the cells expressed immunoreactive NC3*00101 protein.
Following FACS sorting with an anti-bovine MHC class I monoclonal antibody (H1A),
98.4% of the cells expressed the bovine MHC class I protein. NC3*00101-transfected
cells after sorting with H1A antibody had anexpression of 98.4%. The pre-sorting and
post-sorting data are presented in Figure 3-2.

Growth of Cells in Pitched-Blade Bioreactor
NC3*00101-transfected cells grew with a doubling time of 24 hours. The reported
doubling time for this cell line is 18-22 hours. pH was maintained by utilizing CO2 from
the pH cascade. The total number of cells harvested was 3 x 109 cells after 3 days of cell
growth. This was an adequate number for isolation of enough purified NC3*00101
protein for immunization of 10 mice and subsequent screening of the hybridomasupernatants by enzyme-linked immunosorbent assay (ELISA).
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Fig 3-2: Flow cytometric analysis of murine P815 cells transfected with an expression
vector encoding the bovine NC3*00101 protein. Positive, stably transfected cells
were sorted by FACS on the basis of H1A monoclonal antibody staining.

Isolation of BoLA-NC3*00101 Protein
The concentrations of BoLA-NC3*00101-crude cell lysate and purified
concentrated protein sample were 1.9 mg/ml and 0.5 mg/ml, respectively. This was
adequate for the downstream immunization and screening of the hybridoma supernatants
using ELISA.

Western Blot
A Western blot was performed to detect the specific protein in the crude cell
lysate and the purified protein sample. The blot was probed with an antibody that
recognizes the V5 epitope at the C-terminal end of the protein. Untransfected cell lysate
was used as a negative control. Beta-galactosidase protein (120 kD) isolated from cells
transfected with the beta-galactosidase control plasmid was used as a positive control.
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The bovine NC3*00101 class I protein was detected as a 45 kDa band in the crude lysate
and the purified concentrated sample (Figure 3-3).

Fig 3-3 BoLA-NC3*00101 protein (45kD) specifically recognized by anti-V5
antibody

Discussion
The pitched-blade bioreactor was useful in the scale-up of P815 cell growth and
protein production. The product quality did not change as measured by SDS-PAGE and
subsequent detection with Western blotting. It is evident from the trends in DO and pH
values that P815 cells, like CHO cells [12], utilize large amounts of oxygen for
respiration in their early exponential growth phase and thus, acidify the media. Later
during the proliferation phase the pH establishes equilibrium, followed by an elevation in
pH indicating a stationary and death phase. A high pH value at 72 hours indicates high
alkalinity, which possibly is marker of lack of nutrients and cell death.
Stirred tank bioreactors have been used for culturing hybridoma cells in
suspension for monoclonal antibody production [13]. Mouse P815 cells grow well in
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vessels with pitched-blade impellers at moderate agitation rates. Shear sensitivity of
mammalian cells has been an important issue for scaling up production but advances in
technology have helped overcome this limitation.
This study resulted in successful scale-up in production of murine P815 cells
expressing BoLA-NC3*00101 protein using sophisticated, automated bioreactor process
control machinery in batch-culture. This study demonstrated the feasibility of growing
FACS sorted murine P815 cells in a large vessel without loss of protein quality or cell
viability. Bioreactors are an efficient means by which difficult cells can be cultured under
controlled conditions to maintaining cell health and increase productivity.
The non-classical MHC class I proteins are important immunoregulatory
molecules at the maternal-fetal interface. With the generation of antibodies against these
glycoproteins it will be possible to quantify the level of secretion of these proteins at
different stages of pregnancy. With the protein produced in the bioreactor we were able
to produce hybridomas that secrete monoclonal antibodies to the NC3*00101 protein.
Therefore, our findings show that pitched-blade bioreactor is a useful tool to scale-up the
expression of BoLA-NC3*00101 protein by culturing the transfected cells on a large
scale.
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CHAPTER 4
PRODUCTION OF MONOCLONAL ANTIBODIES FOR BoLA-NC3*00101 AND
NC1*00501 PROTEINS
Abstract
We previously identified that cattle classical (MHC-Ia) proteins, N*01701 and
N*01802, and three non-classical (MHC-Ib) proteins, NC1*00501, NC3*00101, and
NC4*00201, are expressed on the cell surface. Other cattle non-classical proteins,
NC1*00401 and NC2*00102, are not expressed on the cell surface and may be secreted
or soluble in nature. To detect secreted or soluble class Ib isoforms produced by bovine
embryos and trophoblast cells and to determine the level of expression of class Ib
immunoregulatory molecules during pregnancy, we immunized mice and developed
monoclonal antibodies for two class Ib proteins, BoLA-NC1*00501 and NC3*00101.
Large numbers of P815 cells expressing NC1*00501 and NC3*00101 proteins were
grown in multiple T75 flasks and/or a pitched blade bioreactor. The polyhistidine or 6Xhistidine-tagged proteins were isolated using His-Gravi trap nickel affinity column
chromatography and were used as immunogens in mice. Monoclonal antibodies were
produced at Washington State University (WSU) Monoclonal Antibody Center.
Screening of sera from immunized mice and culture supernatants from hybridomas was
done by flow cytometry and enzyme linked immunosorbent assay (ELISA). Our
objectives are to use the monoclonal antibodies to develop an ELISA that can be used to
detect soluble MHC-Ib proteins from embryos and trophoblast cells and to use the
monoclonal antibodies in immunohistochemistry to examine the regulation of MHC-Ib
expression at the maternal-fetal interface.
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Introduction
An antibody recognizes a specific linear or conformational “epitope” on the
antigen. While conformational epitopes are dependent on the tertiar structure of the
protein, linear epitope remains intact when the protein is denatured. Polyclonal antibodies
or antisera collected from an animal immunized with a specific antigen contain antibodies
with different specificities and epitope affinities. Monoclonal antibodies are produced by
progeny from a single ancestral B cell from an immunized animal and recognize a single
epitope. B cells from the spleenor a lymph node of an immunized animal are harvested
and cultured in vitro. However, antibody producing B cells have limited life span. B cells
are, therefore, immortalized by fusing them with myeloma cells. Kohler and Milstein [9]
were the first investigators to synthesize “hybridomas” by fusion of mouse myeloma and
mouse spleen cells from an immunized donor mouse. Monoclonal antibodies are purified
from hybridoma culture supernatants or ascitic fluid. Once a hybridoma cell line is
established via single cell cloning, it can be frozen and stored in liquid nitrogen for an
indefinite period. Monoclonal antibody (mAb or MoAb) production technology not only
enables researchers to isolate a specific antibody from an immunized animal but also
allows scientists to produce specific antibodies in large quantity in vitro.
By virtue of their single epitope specificity, monoclonal antibodies decrease
background noise and cross-reactivity with non-specific antigens and give reproducible
results. Use of a mAb allows for efficient affinity purification of the target antigens.
Monoclonal antibodies are used in various diagnostic tests to detect minute quantity of
antigens such as hormones, enzymes, drugs, toxins etc. For instance, in human medicine
detection of human chorionic gonadotropin (hCG) in urine or serum is used for
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pregnancy diagnosis and an ELISA test is used to diagnose AIDS. Rodents are routinely
used to produce monoclonal antibodies. Other animals are not commonly used because of
difficulties in establishing immortalized cell lines by hybridoma formation, viral
transformation or reprogramming [10, 11, 15].
Our objective is to use the mAb against bovine MHC class Ib proteins to develop
ELISA that can be used to detect secreted or soluble BoLA-Ib proteins in: serum from
pregnant cows, culture supernatants from in vitro derived embryos, and culture
supernatants from cultured trophoblast cells from different terms of pregnancy. Surface
expressed bovine MHC class Ib NC1*00501 and NC3*00101 purified proteins were used
to immunize mice. Sera and hybridoma secreting mAbs were tested by ELISA and flow
cytometry to check their specificity.

Materials and Methods
Cell Lines and Transfection
The murine mastocytoma P815 cell line was obtained from American Type
Culture Collection (ATCC, USA). Cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) with 10% bovine calf serum, 100 units/ml penicillin, and 100 µg/ml
streptomycin (Hyclone) at 37°C and 5% CO2. Cells were transfected with bovine MHC
class I proteins. Coding sequences for BoLA-NC1*00501 and NC3*00101 were
amplified from complementary DNA (cDNA) using the specific specific primers shown
below:
Forward Primer CACCATGGGGCCGCGAACCCTC
Reverse Primer for NC1*00501 GATGAAGCATCACTCAGTCCCC
Reverse Primer for NC3*00101 GGCACTGTCACTGCTTGCAGTCTG
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The pcDNA3.1 directional TOPO expression vector (Invitrogen), which expresses
the protein with a C-terminal polyhistidine tag and a V5 epitope, was used for cloning the
cDNA. Subclones were sequenced and NC1*00501 and NC3*00101 subclones were
selected to transfect P815 cells. Cells were transfected using our previously described
method [13]. Transfected cells were fluorescently labeled using specific mAb and
analyzed by flow cytometry to check initial expression. Transfectants were selected with
G418 antibiotic (InvivoGen) and stably transfected cells were sorted using a BD
FACSAria II fluorescence activated cell sorter (FACS). Sorted, high expressing
NC1*00501 and NC3*00101 cells were cultured in multiple T150 flasks for antigen
production. For large-scale antigen production, cells were sometimes grown in a pitchedblade bioreactor. Sorted NC1*00501 cells were cultured in multiple T150 flasks.

Purification of NC1*00501 and NC3*00101 Proteins
Cells were lysed in lysis buffer (50 mM Tris-HCl, 150 mM NaCl with 1 mM
mammalian protease inhibitor cocktail (Sigma), 1 mM PMSF; pH 7.4) with 1 x 107
cells/ml. After an hour-incubation at 4°C, the supernatant was collected by centrifugation
at 10,000 g for 15 min at 4°C.
Specific histidine-tagged NC1*00501 and NC3*00101 proteins were purified
using His-GraviTrap Columns (GE Healthcare) as previously described [13]. Eluates
which had specific protein bands on Western blots were pooled and dialyzed against
phosphate buffer solution (20 mM Sodium Phosphate, 500 mM NaCl, pH 7.4) using 20
kilodalton (kD) molecular weight cut-off (MWCO) Slide-A-Dialysis cassettes (Pierce).
To prevent precipitation and to maximize the stability of proteins, 50 mM charged amino
acids, L-arginine and L-glutamate, were added to all the purification buffers and dialysis
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buffers [8]. Dialysates were centrifuged at 12100 RPM for 10 min at 4°C and the
supernatant was transferred to a sterile tube. Dialysates were concentrated using
Vivaspin-20 concentrators with 30 KD MWCO membranes (Vivaproducts). The
concentration of each fraction was measured using a BCA protein assay kit (Thermo
Scientific).

Immunization
Antibodies to BoLA-NC1*00501 and NC3*00101 proteins were produced at the
monoclonal antibody center at WSU, Pullman using the protocol described by Hamilton
and Davis [6]. Three mice per antigen were hyperimmunized with purified antigen in
Ribi’s Adjuvant (Sigma-Aldrich). Each mouse had four immunizations each with 50 ug
antigen/mouse. Because titer was low with initial immunizations with purified antigens,
subsequent immunizations were done with P815 cells transfected with NC1*00501 and
NC3*00101 cells and mice were boosted with the purified antigens. A final booster dose
of antigen was given intravenously through the tail vein three days before the fusion of
spleen and myeloma cells.

Fusion
For each antigen spleen cells were collected and pooled from three mice. Spleen
cells (~1 x 108) were fused with 4 x 107 X63 Ag8.653 myeloma cells [8]. Fused cells
were resuspended in growth medium containing hypoxanthine aminopterin and
thymidine (HAT) medium and cultured in ten 96-well culture plates. We received three
live cultures (A, B, and C) of each of the NC1-19, NC1-21, and NC1-40 hybridomas
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which were grown and supernatants were collected and screened by flow cytometry and
ELISA.

Flow Cytometry
Flow cytometry was used to test hybridoma supernatants for the presence of
specific antibodies by indirect ELISA and flow cytometry [1]. For screening by flow
cytometry, NC1*00501 and NC3*00101-transfected cells were stained using culture
supernatants and a fluorescein conjugated anti-mouse IgG (H+L) secondary reagent.
Staining was evaluated using a FACSAria II flow cytometer. Untransfected P815 cells
were used as a negative control. Positive hybridomas were expanded in 12-well culture
plates. Two ampoules of each positive hybridoma line were cryopreserved. Positive
cultures were cloned, and the clones were expanded and cryopreserved. Supernatants
from the clones were collected at the time of cryopreservation and characterized by
ELISA, flow cytometry, and Western blotting.

ELISA
ELISA plates (CoStar Inc.) were coated with antigen at a concentration of 16
µg/ml in ELISA binding buffer (0.05M Tris, pH 9.5) and incubated overnight at 4°C.
Plates were washed with 1 X ELISA wash buffer (10X Wash Buffer: PBS with 1.4 M
Sodium Chloride, 0.5% Tween 20, 1% of 20% Sodium Azide) and blocked for 2 hours at
37°C using blocking buffer (Binding buffer with 0.3% Bovine serum albumin, BSA).
Plates were washed four times prior to addition of antibodies. Monoclonal antibodies
H1A, W6/32, H6A, and H11A were used at 1 µg/ml with 100 µl used per well. The
NC1*00501 and NC3*00101 hybridoma supernatants were tested at 1:1 and 1:100
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dilutions of NC1*00501- and NC3*00101-hybridoma culture supernatants in dilution
buffer I (PBS with 0.3% BSA and 0.05% Tween-20). The secondary antibody goat antimouse-biotin was used at 1:10000 dilution in dilution buffer I with 100 µl used per well.
Plates were incubated at 37°C for 1 hour. After washing the plate four times, the
streptavidin-AP diluted 1:1000 in dilution buffer II (PBS with 0.3% BSA) was added and
incubated for 1 hour at 37°C. Finally, freshly made pNPP solution in substrate buffer (50
mM Potassioum carbonate; 2 mM Magnessium Chloride) was added to the wells and
incubated at 37°C. The optical density (OD) at 405 nm was measured at 15 min intervals
from 15 min up to an hour. Data were plotted with time on the X axis and OD on the Y
axis.
For Sandwich ELISA, plates were coated with antibodies or hybridoma culturespernatants overnight at 4°C. After blocking the plate, purified cattle class I antigens
were added. A biotinylated W6/32 antibody was used as detection antibody. In other
studies capture (sandwich) ELISA are routinely used to detect the soluble class I proteins
[3, 4, 5, 7, 14].

Production of Exhausted Hybridoma Culture Supernatants
Exhausted culture supernatants for the NC3*00101 antigen were prepared at
Washington State University while exhausted culture supernatants for the NC1*00501
antigen were prepared at Utah State University. Cells were thawed, enumerated and
cultured in a 6-well plate at a seeding concentration of 1 x 106 cells/ml in RPMI with 1%
Zap Hybridoma supplement (InVitria). After 1 week of culture, cells were transferred to a
T25 flask. When the cells were ~90% confluent, they were transferred to T75 flasks.
Multiple T75 flasks were inoculated with 5 million cells in 50 ml of culture medium and
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cultured at 37°C at 5% CO2 for a week by which time the media was exhausted and cells
had died. The exhausted supernatants containing antibodies were collected by
centrifugation at 1500 RPM for 10 min.

Antibody Isotyping
The NC3*00101- and NC1*00501-hybridoma culture supernatants were screened
using an ELISA murine antibody isotyping kit (Pierce) to determine the isotypes of the
antibodies. H1A, W6/32 and IL-A88 were used as positive controls.

Results
Establishment of High-Expressing Transfected Cell Lines
Less than 20% of newly transfected P815 cells expressed BoLA-NC1*00501 or
NC3*00101 proteins that could be detected by flow cytometry. Growth in G418
antibiotic was used to select stable transfectants. Following two weeks of selection
approximately 25-50% of the cells expressed immunoreactive NC1*00501 or
NC3*00101 proteins. Following FACS sorting with an anti-bovine MHC class I
monoclonal antibody (H1A), 92.3% of NC1*00501 and 98.4% of NC3*00101 cells
expressed the bovine MHC class I protein. Pre-sort and post-sort data are presented in
Figure 4-1.

ELISA Screening
Antibodies against NC1*00501
First Fusion: Supernatants NC1-19, NC1-21, and NC1-40 had positive reactivity
sin the initial screening ELISA (data not shown). The NC1-19 supernatant had stronger
reactivity than other two supernatants. Exhausted supernatants were produced and used to
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test the monoclonal antibodies against all of our cloned MHC class I proteins. These
supernatants reacted with all of the cattle MHC class I proteins but had higher affinity for
NC1*00501 protein (Figure 4-2). NC1-19, which appeared to be strong in ELISA, did not
appear to be a true clone in isotyping assay (Figure 4-2).

Fig 4-1: Presort and post sort analysis of NC1*00501 and NC3*00101 transfectants

NC3*00101
First Fusion: NC3*00101-specific antibody secreting hybridomas were screened
by ELISA and flow cytometry at WSU. Twelve positive NC3 hybridoma colonies were
found positive from the first fusion. NC3-4 and NC3-9 were slightly positive in ELISA.
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Second Fusion: From the second fusion of spleen cells with myeloma cells, one
positive hybridoma (NC3 supernatant 2) clone was selected and the supernatant was sent
to us for secondary screening. NC3-02 clone had a specific and positive reactivity with
NC3*00101 protein as determined by ELISA (Figure 4-3).

Fig 4-2: ELISA screening of anti-NC1*00501 exhausted supernatants
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Fig 4-3: ELISA screening of NC3*00101 supernatants. Note that NC3 supe 2 has a
specific reaction with NC3*00101 protein as shown in the last line graph with the crossed
purple line of NC3 supe 2.
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Third Fusion: From the third fusion, 7A and 7B supernatants were positive in
initial screening but they were non-specific and reacted with all other class I proteins
(Table 4-1).

Table 4-1: The summary of ELISA results of NC1 and NC3 supernatants
mAb

N*01701

N*01802

NC1*00501

NC3*00101

H1A

-

++++

++

+++

W6/32

-

+++

++++

-

IL-A88 neat

++++

++++

-

++++

IL-A88 1:10

++++

++++

-

++++

NC1-19A 1:10

+++

++

++++

+++

NC1-19A 1:100

-

-

-

-

NC1-21A 1:10

-

-

-

-

NC1-21A 1:100

-

-

-

-

NC1-40A 1:10

++

+

+++

+

NC1-40A 1:100

+

-

++

+/-

NC3-supe 2

-

-

-

++++

NC3-1

-

-

-

-

NC3-2

-

-

-

-

NC3-3

-

-

-

-

NC3-4

+

+

+

+

NC3-5

-

-

-

-

NC3-6

-

-

-

-

NC3-7

-

-

-

-

NC3-8

-

-

-

-

NC3-9

++++

++

++

++++

NC3-10

-

-

-

-

NC3-11

-

-

-

-

NC3-12

-

-

-

-

91

Flow Cytometry
NC1*00501
In the initial screening of NC1 serum from immunized mice, we saw a strong
NC1-specific response. However, it also produced a weak response to untransfected P815
cells. In the first fusion one NC1 hybridoma was positive; however, there was no
outgrowth after transfer to the 12-well plate. The second fusion yielded positive
hybridomas whose expanded supernatants were tested with flow cytometry.
First Fusion: One supernatant NC1-19 had a detectable activity but it reacted
with other cell lines including untransfected P815 cells. As shown in Table 4-2, 11 of the
supernatants (#24, #25, #27, #28, #30, #33, #34, #36, #38, #40 and #41) appeared to have
a low titer against NC1*00501 protein. They all seemed to be the mixed population. We
rescreened all supernatants with 1:1 and 1:10 dilutions of supernatants. The titer of
antibody in all anti-NC1 supernatants was likely low. NC1-19A and 40A reacted more
strongly with untransfected P815 cells than with NC1*00501-transfected cells (Figure 44).

NC3*00101
First Fusion: None of the twelve sera was positive.
Second Fusion: Supernatants of NC3-1 and NC-9 hybridomas reacted with all
cattle MHC-I proteins with a weak reactivity to untransfected P815 cells which suggests
that these supernatants may have reacted with unknown cell-cycle antigen on mouse
P815 cells as mice were immunized with transfected P815 cells. We did not see any
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specific reactivity in the NC3-9 supernatant. Consequently, we did not clone NC3-1 and
NC3-9 hybridomas.

Fig 4-4: Flow-cytometry staining of culture supernatants of NC1*00501-hybridomas.

Third Fusion: From the third fusion of spleen cells, initial screening produced
ten NC3 positive clones. However, only two of them expanded. These were frozen. We
received supernatants of NC3-1, NC3-2 and NC3-3 from the third fusion. The NC3-2
supernatant looked very promising and positive on NC3*00101-transfected cells even at
1:100 dilution (Figure 4-5). We decided to clone the NC3-02 clone from the third fusion.
Cloning of the NC3-02 hybridoma cell line was attempted twice at WSU, but the cell line
was not cloned or rescued. More fusions were attempted but all the clones had non-
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specific reactivities. From the third fusion we cultured NC3-2 (A, B, C, D, E, F), NC3-4
(A, B, C, D, E, F), NC3-7 (A, B), and NC3-8 (A, B, C, D, E, F) cell lines and tested them
by flow cytometry. 7A and 7B supernatants reacted with the NC3*00101-transfected cell
line but they also reacted with untransfected P815 cells with the same intensity.

Fig 4-5: Flow-cytometry staining of culture supernatants of NC3*00101-hybridomas.
Note that BoLA-NC3*00101-NC3-Supernatant 2 neat has a specific positive response
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Antibody Isotyping
All NC3*00101 and NC1*00501-hybridoma culture supernatants secreted IgG1
isotypes of immunoglobulins. As expected H1A, W6/32, and IL-A88 antibodies were of
IgG2a isotypes. All samples tested were found to have kappa light chains (Table 4-2).

Table 4-2: Summary of Isotyping of NC1*00501 and NC3*00101 supernatants
mAb

Isotype

Light Chain

H1A

IgG2a

Kappa

IL-A88

IgG2a

Kappa

W6/32

IgG2a

Kappa

NC1-19A

IgG1

Kappa

NC1-21A

IgG1

Kappa

NC1-40A

IgG1

Kappa

NC3-2 original

IgG1

Kappa

NC3-5

IgG1

Kappa

NC3-6

IgG1

Kappa

NC3-9

IgG1

Kappa

NC3-10

IgG1

Kappa

NC3-11

IgG1

Kappa
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Discussion
The report of bovine monoclonal antibody to red blood cell antigen was published
by Tucker et al. 1987 [16]. Monoclonal antibodies against cattle MHC-I, IL-A88 and ILA19, were produced at International Laboratory for Research on Animal Diseases
(ILRAD), Kenya. In one study, researchers noticed that the MHC-I specific antibodies
recognized MHC class I heavy chain on Western blot [2]. We tested H1A, H6A, H11A,
PT-85A antibodies but they did not work on Western blot. It is reported that in nonreducing Western blotting conditions, they may all react with the light chain (Beta-2
microglobulin) [12].
To develop ELISA to detect secreted proteins from trophoblast cell culture
supernatants, we attempted to develop monoclonal antibodies against two bovine class Ib
molecules, NC1*00501 and NC3*00101. We were able to produce a hybridoma cell line
which secreted NC3-specific antibodies. Unfortunately, the NC3-2 hybridoma, which
produced specific and high-titer anti-NC3*00101 antibody, was not recovered and thus
we failed to retain the positive hybridoma. We were able to use the NC3-2 original
supernatant in ELISA as a capture antibody for NC3*00101 protein.
In the future, we need to perform more fusions and screenings of hybridomas to
produce a positive hybridoma that is more stable and able to secrete specific antibodies in
the supernatant. The use of transfected murine P815 cells as immunogens may also be
one of the considering factors as the hybridoma supernatants reacted with untransfected
cells when tested on flow cytometry. Using an MHC-null cell line such as human K562
and/or another host animal for immunization are parameters to consider for future
projects to produce cattle class Ib specific antibodies.

96
References
1. Davis WC, Davis JE, Hamilton MJ. Use of monoclonal antibodies and flow cytometry
to cluster and analyze leukocyte differentiation molecules. In: Davis WC (eds.),
Monoclonal Antibody Protocols, Methods in Molecular Biology, vol. 45. Totowa, NJ:
The Humana Press; 1995: 149-167.
2. Davis WC, Marusic S, Lewin HA, Splitter GA, Perryman LE, McGuire TC, Gorham
JR. The development and analysis of species specific and cross reactive monoclonal
antibodies to leukocyte differentiation antigens and antigens of the major
histocompatibility complex for use in the study of the immune system in cattle and other
species. Vet Immunol Immunopathol 1987; 15:337-376.
3. Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human
embryos associated with higher pregnancy and implantation rates: assay of culture media
using a new ELISA kit. Reprod Biomed Online 2006; 13:272-277.
4. Fournel S, Huc X, Aguerre-Girr M, Solier C, Legros M, Praud-Brethenou C, Moussa
M, Chaouat G, Berrebi A, Bensussan A, Lenfant F, Le Bouteiller P. Comparative
reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules.
Tissue Antigens 2000; 55:510-518.
5. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci
A, Baricordi OR. HLA-G expression in early embryos is a fundamental prerequisite for
the obtainment of pregnancy. Eur J Immunol 2002; 32:311-315.
6. Hamilton MJ, Davis WC. Culture conditions that optimize outgrowth of hybridomas,
1995. p. 17-28, Monoclonal Antibody Protocols, Methods in Molecular Biology, vol. 45.
The Humana Press Inc., Totowa, N.J.

97
7. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLAG and IL-10 in serum in relation to HLA-G genotype and polymorphisms.
Immunogenetics 2004; 56:135-141.
8. Kearney JF, Radbruch A, Liesegang B, Rajewsky K. A new mouse myeloma cell line
that has lost immunoglobulin expression but permits the construction of antibodysecreting hybrid cell lines. J Immunol 1995; 123:1548-1550.
9. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of
predefined specificity. Nature 1975; 256:495-497.
10. Kurosawa N, Yoshioka M, Fujimoto R, Yamagishi F, Isobe M. Rapid production of
antigen-specific monoclonal antibodies from a variety of animals. BMC Biol. 2012;
10:80:1-14.
11. Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, Lukens MV,
van Bleek GM, Widjojoatmodjo MN, Bogers WM, Mei H, Radbruch A, Scheeren FA,
Spits H, Beaumont T. Generation of stable monoclonal antibody-producing B cell
receptor-positive human memory B cells by genetic programming. Nat Med 2010;
16:123-128.
12. Li W, O’Reilly KL, Davis WC, Splitter GA. Bovine major histocompatibility
complex class I specific monoclonal antibodies characterized by flow cytometry, oneand two-dimensional electrophoresis, Western blot and inhibition of cytotoxic T
lymphocyte function. Vet Immunol Immunopath 1992; 33:309-320.
13. Parasar P, Barnett S, Wilhelm A, Rashid K, Davies CJ. Large-scale growth of mouse
P815 cells expressing a bovine non-classical major histocompatibility complex class I
protein utilizing a pitched-blade bioreactor, Bio Process J, 2012; 11(3): 27-34.

98
14. Sargent I, Swales A, Ledee N, Kozma N, Tabiasco J, Le Bouteiller P. sHLA-G
production by human IVF embryos: Can it be measured reliably? J Reprod Immunol
2007; 75(2):128-132.
15. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR,
Murphy BR, Rappuoli R, Lanzavecchia A. An efficient method to make human
monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.
Nat Med 2004; 10:871-875.
16. Tucker EM, Clarke SW, Metenier L. Murinelbovine hybridomas producing
monoclonal alloantibodies to bovine red cell antigens. Anim Genetics 1987; 18, 29-39.

99
CHAPTER 5
IDENTIFICATION OF THE PEPTIDE MOTIFS OF CATTLE NON-CLASSICAL
MHC-I (BoLA-NC3*00101) PROTEIN

Abstract
We eluted and identified peptides which bind to the peptide binding groove of the
NC3*00101 protein. We used a MHC-null K562 cell line, which only expresses the
transgene. K562 cells were transfected with the bovine transgene coding for NC3*00101
protein and grown on a large scale. Peptides were released and eluted using mild acid
treatment. After purification with reverse phase high pressure column chromatography
(RP-HPLC) and mass-spectroscopy (MS) the peptide sequences were identified.
Sequences were matched with the mammalian database of National Center for
Biotechnology Information (NCBI). Candidate peptide-sequences were identified by
creating sequence logos (http://weblogo.berkeley.edu/logo.cgi) and comparing with
human non-classical class I specific peptide ligands. Candidate peptides were tsted for
their specificity in refolding assays and peptide binding assays. Our results indicate that
peptide EVTNQLVVL is potential peptide ligand of NC3*00101 protein as identified by
peptide binding assay and statistical analysis using mixed procedure of statistical analysis
software (SAS).

Introduction
There are two types of major histocompatibility complex class I (MHC) proteins,
classical (MHC-Ia) and non-classical (MHC-Ib) class I glycoproteins. Class I proteins
bind with intracellular pathogen-derived peptides or the animal’s own peptides and
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present these peptides to the cell surface for cytotoxic T cell-receptor interaction. Selfpeptides normally do not elicit a cytotoxic T-response owing to their tolerance to selfantigens. In bacterial, viral, and other infections, peptides produced from the foreign
pathogen are subsequently loaded onto peptide binding grooves of MHC-I glycoproteins
for presentation on the cell surface and immunological recognition by class I restricted
cytotoxic T cells. Thus, an infected cell with a foreign peptide in the MHC-I peptidebinding groove is recognized and destroyed by cytotoxic T cells.
Binding of peptides to the peptide binding groove is critically important for the
expression of MHC-I proteins on the cell-surface. Class I specific peptides are 8-10
amino acid long. These peptides tighly bind in the groove with their N- and C- termini
buried interacting with MHC residues. Side chains of peptide amino acid residues interact
with corresponding MHC residues to form pockets that vary in shape and location
depending on the allelic forms of the MHC molecules [31]. MHC-Ia proteins have been
studied to a significant extent in terms of their peptide presentation characteristics.
Extremely polymorphic MHC-Ia proteins present a vast array of peptides to T cells. On
the other hand, MHC-Ib proteins bind with a narrow range of peptides. Human MHC-Ib
proteins, human leukocyte antigen (HLA)-E and HLA-G display more restricted sets of
peptides than classical HLA-A, -B, and -C antigens. HLA-E binds peptides derived from
leader sequences from certain HLA class I leader sequences [3, 4, 21, 22]. HLA-G binds
naturally processed endogenous peptides [6, 23]. HLA-F is uniquely expressed as empty
MHC-I protein [10]. The murine class Ib molecule Qa-2 binds nonapeptide which has a
histidine as an anchor residue at P7 [18].
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MHC-Ib proteins are important immunomodulatory proteins which interact with
immunoglobulin-like receptors, LILRB1 and LILRB2, and inhibit immune cells [1, 2, 9,
13, 14, 15, 24, 28, 35]. Soluble HLA-G isoform, HLA-G1 induces maternal fetal
tolerance uterus by inducing apoptosis of activated CD8 T cells [9]. It also inhibits NK
cell-mediated cytotoxicity [25, 29, 30, 34].
The MHC of cattle, bovine leukocyte antigen (BoLA), encodes class Ib proteins at
four loci, BoLA-NC1, -NC2, -NC3, and -NC4. It is known that class Ib proteins undergo
alternative splicing so as to produce membrane and secreted isoforms. During the third
trimester of pregnancy, cattle trophoblast cells express both class Ia and class Ib protein.
The characteristic features of BoLA-Ib proteins are less polymorphism (monomorphic or
oligomorphic), putative class Ib amino acid motifs (IPI, VPI or VLI) in their
transmembrane domains and/or premature stop codons, and surface and/or soluble
isoforms due to alternative splicing in the transmembrane domain [5]. Transfection
studies revealed that BoLA-Ia proteins, N*01701 and N*01802, and BoLA-Ib proteins,
NC1*00501, NC3*00101, and NC4*00201, are expressed on the cell-surface.
NC3*00101 protein is expressed at a high level compared to other BoLA-Ib proteins, and
is an important immunoregulatory molecule. It is important to investigate peptide motifs
that bind with NC3*00101 protein to understand the mechanism of immune tolerance of
this protein during pregnancy.
Endogenous peptides associated with MHC-I proteins can be identified using
reported methods [33]. MHC-I bound peptides can be acid extracted from whole cells [7,
8, 31, 32, 33, 36, 37] or they can be acid-eluted from purified MHC-I molecules [6, 7, 8].
Although the elution of peptides from purified MHC-I proteins gives better results, citrate
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shock or mild acid-elution can also be a method of choice when a MHC-I specific
antibody capable of working in immunoprecipitation is not available.
We transfected a K562 cell line with a cattle NC3*00101 transgene and used the
citrate shock method to elute peptides after mild acid treatment of transfected cells.
Peptides were purified using chromatography and analyzed by liquid chromatography
mass-spectroscopy (LC-MS) to identify sequences of peptides extracted from
NC3*00101-transfected K562 cells.

Materials and Methods
Cell Lines and Culture Conditions
The MHC-null cell line K562 (ATCC CCL243) is a lymphoblastic cell line
derived from a person with chronic myelogenous leukemia (CML). Cells were cultured
and maintained at 37°C and 5% CO2 in Iscove’s Modified Dulbecco’s Medium (IMDM)
(Fisher Scientific) with 10% heat-inactivated bovine calf serum (Hyclone), 100 units/ml
penicillin and 100 µg/ml streptomycin (Hyclone) in a humidified incubator.

Flow Cytometry
The BoLA-NC3*00101 gene was amplified (Forward primer
CACCATGGGGCCGCGAACCCTC and reverse primer
GGCACTGTCACTGCTTGCAGTCTG) and cloned in the pcDNA3.1 mammalian
expression vector. Subclones were sequenced to confirm the size of insert and full length
subclones were used to isolate the plasmid using a Qia-prep kit (Qiagen). Cells were
transfected with the subclones of the NC3*00101 gene in the pcDNA3.1 vector using
Lipofectamine 2000 (Invitrogen) transfection reagent. Untransfected cells were used as a
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negative control. Four micrograms plasmid DNA was used to transfect 2 x 106 cells using
the method described in the chapter 3. For staining, cells were resuspended in
fluorescence buffer (FB; PBS with 0.1% sodium azide, 1% bovine serum albumin) and
incubated with anti-MHC class I monoclonal antibody W6/32 (15µg/ml) for 15 min.
Cells were washed twice with FB and then incubated with secondary antibody for 15
min. All incubations were performed at 4°C. Cells were washed twice and fixed in PBS
with 1% formaldehyde or paraformaldehyde. One million cells were stained for each
sample. Cells were analyzed using a Becton-Dickinson FACSAria II fluorescence
activated cell sorter (FACS) equipped with FACS Diva software. The FACSAria II was
also used to sort the transfected cells to enrich the high expressing cells.
For FACS sorting, cells were stained in IMDM medium using the method
described above. Stable NC3*00101 transfectants of K562 cells were cultured in T150
flasks and monitored by counting the cells and visualizing daily under a microscope.

Mild-Acid Elution of NC3*00101-Peptides
Stably transfected and highly expressing NC3*00101-transfectants were
harvested (~1 x 109 cells) by centrifuging cells at 2000 xg at 4°C for 10 min. Cells were
washed twice with phosphate buffered saline (PBS) by spinning each wash at 2000 xg for
5 min. Cells were incubated on ice for 5 min. Ice-cold citrate shock buffer (0.131 M citric
acid, 0.066 M Na2HPO4, and 150 mM NaCl, pH 3.3) was added to cells at 1 ml/108 cells.
Cells were resuspended and incubated on ice for 5 min. Cells were spun down to remove
the cell debris and supernatant was collected in a sterile 15 ml centrifuge tube (Corning).
Cells were centrifuged at 15000 RPM for 30 min to clear the supernatant of the
precipitated material to avoid the blockade of centrifugal filters in the subsequent
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procedure. In the meantime, 3 kD MWCO centrifugal filters (Amicon) were washed with
50% methanol and liquid chromatography-mass spectrometry (LC-MS) grade-water
(Optima) by centrifuging filters at 4000 RPM for 30 min. Clear supernatant from citratetreated cells was added to the filter and centrifuged at 4000 RPM for 30 min. Flow
through containing peptides lower than 3 kD size was collected and pooled. The pooled
flow through was vaccum concentrated to 500 µl and purified using reverse-phase-high
pressure liquid chromatography (RP-HPLC) C18 Zip Tip (Millipore). Peptide extractions
were performed in three replicates each of ~1 x 109 cells and analyzed by mass-assisted
laser desorption ionization (MALDI) mass spectroscopy for initial analysis of massspectra to identify the presence of peptides and potential m/z peaks of interest. Synthetic
peptide (YPAIPVLQI), which is the reported peptide motif of cattle class I antigen
BoLA-A11 or N*01701 protein (http://www.ebi.ac.uk/ipd/mhc/bola/index.html) [11, 12]
was ordered from Genscript and used as a positive control reference peptide for the
MALDI protocol.

MALDI and LC-FT MS/MS
MALDI and liquid chromatography Fourier Transform (LC-FT) MSMS analyses
were carried out at the mass spectrometry and proteomics core facility, University of
Utah, Salt Lake City. Briefly, peptide samples were spotted using the dried-droplet
method. The matrix, α-cyano-4-hydroxy cinnamic acid (CHCA), was prepared in
water/acetonitrile [50:50] with 0.1 % trifluoroacetate (TFA) by thoroughly mixing the
matrix powder with 0.5 mL of solvent in a 1.7 mL eppendorf tube, and centrifuging to
pellet the undissolved matrix. The supernatant was used for sample preparation for
MALDI analysis. Peptide samples (0.5 uL of 1 pmol/uL) were loaded onto a stainless
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steel target plate and mixed on the target with 0.5 µL of supernatant of saturated matrix
solution. After the sample spot was air-dried and the mixture of matrix supernatant and
peptide co-crystallized, the spot was ablated with a 1 kHz smartbeam-II™ laser from the
plate while the sample was simultaneously desorbed, ionized, and then accelerated into a
flight tube. The MALDI spectrum was acquired in reflector mode, which was operated at
around 30,000 resolutions over a mass range from 500 to 5000 Da.

LC/MS Analysis of Peptides
LC-MS/MS analysis was performed using a LTQ-FT hybrid mass spectrometer
(ThermoElectron Corp) equipped with Ion Trap Fourier Transform Ion-Cyclotron
Resonance (FT-ICR) technologies. Primary mass spectra were acquired with the (FTICR) part of the instrument. MS/MS fragmentation spectra (i.e. peptide sequence
information) were acquired in the Ion Trap part of the instrument. Peptide molecular
masses were measured by FT-ICR, yielding primary mass spectra of peptides with mass
errors typically less than 3 ppm. Peptide sequencing was performed by collision-induced
dissociation (CID) in the linear ion trap of this hybrid instrument yielding fragment ions
with mass errors typically less than 0.3 Da. Peptide samples were introduced by a
nanoLC column (2D-Ultra, Eksigent, Inc.) with nano-electrospray ionization spray
(ThermoElectron Corp). Typically about 10 to 20 fmoles of peptide samples were
injected. NanoLC chromatography was performed using a homemade C18 nanobore
column (75 um ID x 10 cm; Atlantis C18, 3 µm particle-C18 material from Waters Corp)
at the University of Utah, Mass Spectrometry and Proteomics -Core Facility. Peptides
were eluted during a 78-min linear gradient from 5% acetonitrile (with 0.1% formic acid)
to 60% acetonitrile (with 0.1% formic acid) with a flow rate of 350 nl /min.
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Peptide ID and Database Searches
All identified peptides were assigned from protein database searches, using inhouse processing with the MASCOT search engine (in-house licensed, ver. 2.2.1, Matrix
Science, Inc.) at the University of Utah, Mass Spectrometry and Proteomics Core
Facility. Mascot searching was performed from an in-house computer using a search of
the NCBI protein database. Peptides mass spectra data were searched with non-enzymespecific cut sites and identified based on the “MS/MS” Mascot search option, with the
following criteria:
1)

Accurate mass measurement of peptide molecular ions by FTMS with search

window 5 ppm (peptides typically had less than 3 ppm mass error). Molecular ions with
+1, +2, or +3 charge states determined from a FTMS primary mass spectrum (LTQ-FT
instrument) were usually considered.
2)

Peptide sequence information from MS/MS; CID fragmentation of the parent ion

of each peptide was obtained in the linear ion trap region of the LTQ-FT instrument.
Mass error tolerance of 0.5 Da was allowed for peptide fragment ion masses in the search
(MS/MS fragment ions typically had errors less than 0.3 Da).
3)

Mass spectra peak lists for the Mascot searches were generated using Sequest in

QualBrowser software (Excalibur, Thermo Electron Corp.).
4)

Peptide modification was included in the search (e.g. oxidation on methionine).

5)

Searches were typically performed for non-specific peptide cleavages. Two

missed cleavages were allowed.
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6)

All identified peptides showed MASCOT scores greater than 20. Mascot

threshold cutoffs for acceptable identified peptides had MASCOT scores >20, mass
errors <3 ppm, and expected values less than 1.

Purification of NC3*00101-BSP and Bovine β2m Inclusion Bodies
The NC3*00101 heavy chain was fused with a sequence that can be biotinylated
with a biotinylating enzyme (BirA). This sequence tag is therefore known as BirA
substrate peptide (BSP*41) tag. The NC3*00101-extracellular domains (alpha 1, 2, and 3
domains) or heavy chain was amplified from genomic DNA and cloned in pTCF33
vector (a generous gift from the NIH Tetramer Facility, Emory University) which
expresses the MHC-I heavy chain-BSP (BSP*41) sequence in E. coli. The pTCF33
contains a hybrid T7-lac promoter that drives expression of MHC-BSP chain. Bovine
β2m was expressed into pET24a+ vector as per the NIH Tetramer Facility Protocol
(http://tetramer.yerkes.emory.edu/client/protocols#1). The primers for both the
NC3*00101-BSP and bovine β2m were designed so that the amplicons contain the Bam
H1 restriction site. Clones were sequenced and checked for the correct insert size. E. coli
BL21 cells were inoculated with full size subclones and grown as per the NIH protocol.
Overinduction of expression was carried out using 1 mM Isopropyl β-D-1thiogalactopyranoside (IPTG). Cells were harvested by centrifuging at 4000 RPM for 30
min. Bacteria were pooled and resuspended in 50 mM Tris-HCL, 25% (W/V) sucrose, 1
mM EDTA, 0.1% (w/v) NaAzide, and 10 mM freshly added DTT and the suspension was
stirred in a 100 ml beaker with a stirring bar. To the stirring mixture was added, 1.2 ml 50
mg/ml lysozyme (final = 1 mg/ml), 300 µl 1.0 M MgCl2 (final=5mM), 1.0 ml of 2 mg/ml
Dnase I in 50% glycerol containing 75 mM NaCl, 600 ul Triton-X 100 (final= 1%), and
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600 µl 1M DTT (final=10 mM). The suspension was stirred for 30 min at room
temperature and then sonicated for 1.5 min at 0.5 sec alternations at power 4 using
sonicator. The suspension was centrifuged in multiple 50 ml centrifuge tubes (Corning)
in a Beckman centrifuge at 10000 RPM for 10 min at 4°C. After decanting the
supernatant, 1-2 ml of wash buffer, pH 8.0 (50 mM Tris-HCl, 0.5% Triton-X100, 100
mM NaCl, 1 mM EDTA, 0.1% Na-azide, 1 mM DTT added fresh) was added to the
pellet. The pellet was resuspended, and centrifuged again. After two washes with wash
buffer with Tween-20, cells were washed with wash buffer without Tween-20 and
centrifuged. The final white pellet was solubilized in 10 ml urea solution, pH 6.0 (25 mM
MES (pH 6.0), 8 M urea, 10 mM EDTA, and 0.1mM DTT added fresh). The protein
concentration was measured at A280 measurement on a Nano drop Spetcrophotometer.
Urea solubilized bodies were frozen at a concentration of 2 mg/ml concentration.

Refolding of Cattle NC3*00101-BSP and β2m Chains and Biotinylation
Refolding was carried out in 500 ml of folding buffer (400 mM L-arginine, 100
mM Tris, 2 mM EDTA, pH 8.3) chilled at 10°C. To 500 ml refolding buffer, were added
0.76825 g reduced glutathione, 0.15315 g oxidized glutathione, and 0.5 ml 200 mM
PMSF. Synthetically ordered peptides (15 mg) were dissolved in 500 µl DMSO and
added to the stirring reaction. Urea solubilized inclusion bodies (500 nmol NC3*00101BSP and 1000 nmol bovine β2m) were diluted in injection buffer (3 mM Guanidine HCl,
10 mM Sodium Acetate, 10 mM EDTA; pH 4.2) were loaded into two separate 3 cc
syringes using 20 gauge needles and injected forcefully into the stirring reaction on a stir
plate. The reaction was incubated at 4°C with stirring overnight. Next morning, 500 nmol
of NC3*00101-BSP chain was injected into the reaction followed by 500 nmoles
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NC3*00101-BSP in the evening. Folding reaction was incubated for 2 more days at 4°C.
After 3 days of incubation, reaction was concentrated using 5 kD cut off filters
(Millipore) to 7.5 ml and buffe-exchanged with 10.5 ml biotinylation buffer (100 mM
Tris, 200 mM NaCl, 5 mM MgCl2, pH to 7.5) using PD-10 Sephadex G-25M columns.
To 10.5 ml reaction, were added 500 µl ATP (100mM stock), 40 µl Biotin (100mM
stock), 10 µl Leupeptin (1000x stock), 10 µl Pepstatin (100x stock), 20 µl PMSF (0.1M
stock), and 20 µl BirA enzyme (Avidity) (stock at ~ 1 mg/ml) and the reaction was
biotinylated by incubating overnight at RT.

Purification of Biotinylated MHC-Peptide Monomers on the Mono Q Column
Biotinylation reaction was buffer-exchanged with 20 mM Tris, pH 8.0 using
Amicon Ultra-15 centrifuge filtering device 10 kD MWCO (Millipore). Final
concentrated sample was dissolved in 500 µl Tris buffer. The concentrated sample was
transferred to an eppendorf tube and centrifuged at 15300 RPM for 15 min at 4°C to
remove any precipitate. The concentrated sample (500 µl) was immediately processed for
Mono Q 5/5 purification column (GE Healthcare) using Buffer A (20 mM Tris, pH 8.0)
and buffer B (20 mM Tris, pH 8.0 and 500 mM NaCl). Briefly, 2 ml loop was washed
two times with 2 ml of 20 mM Tris (pH 8.0). FPLC computer program was opened and
set to run the Mono Q column. The parameters were enetered manually and the program
was run for 2 hours until the MHC peaks showed up. The fractions were collected in 4 ml
polypropylene tubes. The specific fractions were pooled and concentrated using 10 KD
MWCO Amicon filters. The sample was concentrated <1 ml and the final sample was
diluted with ~1 ml PBS. The sample was transferred to an eppendorf tube and stored on
ice or 4°C. Protein concentration was measured using A 280 absorbance on a Nano drop
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spectrophotometer and the monomer samples were diluted with PBS to achieve the
concentration of 2 mg/ml.

Western Blotting Analysis of Biotinylated Refolded MHC-Peptide-β2m Complex
To 3 µl of diluted monomer samples from the previous step, was added 12 µl of
PBS (Final concentration 0.4 mg/ml). Five microliters of this monomer sample was
added with 5 µl of 0.8-1 mg/ml streptavidin or water and incubated for 1 hour at room
temperature (RT). Samples were run on NuPAGE 4-12 % Bis-Tris gel and Coomassie
stained to identify the biotinylated heavy chains to shift when treated with Streptavidin
(Biotinylation Shift Assay). For Western blotting, the incubated samples were run on the
gel and transferred to polyvinylidine diflouride (PVDF) membrane. The membrane was
incubated with anti-mouse β2m polyclonal (Novus Biologicals) or W6/32 (VMRD Inc.)
antibodies for an hour at RT. Anti-mouse AP-conjugated antibody was used as secondary
antibody. Both denaturing and native conditions were used to test the antibodies to detect
refolded protein complexes.

Peptide Binding Assay
In a 24-well plate, 0.5 x 106 cells (transfected or untransfected) were added.
Untransfected K562 cells were used a negative control in each experiment. All cells were
treated with or without peptides and incubated at 37°C for 16 hours. Cells treated with
DMSO (carrier) were used as reference sample for analysis. Cells were analyzed for
NC3*00101 expression using anti-MHC class I antibody, W6/32. Peptides tested were
YPAIPVLQI, EVTNQLVVL, LVDGVKRIL, SSKIVGDLA, and GSILSGTAIA. Results
were analyzed by creating overlays of flow cytometry data using FlowJo software.
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Statistical Analysis
Peptide binding assays were performed and mean fluorescence values were
recorded for cell samples. DMSO-treated cells were taken as control and peptides as
mentioned above were used as unknown treatment groups. Different days were used as
covariables. A mixed procedure using statistical analysis software (SAS) was used to
identify significant effects of peptide-treatments on NC3*00101 expression. The least
square means and differences between the means were determined for different treatment
groups to identify the differences of significance between each peptide. P-value of 0.5
was used to identify the values of significance.

Results
Flow Cytometry
K562 cells transfected with NC3*00101 transgene showed 22.4% expression
compared to untransfected cells. We were able to sort highly expressing cells using
W6/32 staining. Three sorts were performed which resulted in enrichment of highly
expressing cells with an expression level of 90.3% (Figure 5-1).

MALDI and LC-MS/MS Analyses
The mass spectrum of reference peptide YPAIPVLQI yielded a specific m/z peak,
which corresponded to a 1013.61 dalton molecular weight (expected MW 1013.65). We
had few m/z peaks of interest in the NC3*00101-peptide sample which led us to proceed
to subsequent LC-MS/MS analysis on NC3*00101 samples (Figure 5-2).
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Fig 5-1: Sorting of K562-NC3*00101 transfectants was performed using antiMHC-I monoclonal antibody W6/32

LC-MS/MS Analysis of NC3*00101 Extracted Peptides
Three different analyses were performed using web sequence logo and manual
comparisons. Peptide sequences were sorted into 8, 9, and 10-amino acid sequences,
which were unique to NC3*00101-transfected cells and different from peptides extracted
from untransfected K562 cells. As MHC-I specific peptides are nonamers, we focused on
9-mer peptides. Sequence logos were created and compared with other MHC class I
specific peptide residues. Four candidate peptides were selected which had non-polar
amino acids at -COOH terminals as reported [31]. Both from sequence logos
(http://weblogo.berkeley.edu/logo.cgi website, Figure 5-3) and manual sorting methods,
candidate peptide motifs of NC3*00101 protein were chosen and ordered from
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Fig 5-2: MALDI spectra of synthetic (YPAIPVLQI) and acid-eluted peptides from
untransfected-K562 cells and transfected NC3*00101-K562 cells

114

Fig 5-3: Logos created with 9-amino acid long peptides identified with the LC-MS/MS
on citrate-acid-eluted peptides

GenScript. These were EVTNQLVVL, LVDGVKRIL, SSKIVGDLA, and
GSILSGTAIA.

Refolding of Heavy and Light Chains and Western Blotting
NC3*00101-BSP and bovine β2m were successfully expressed in bacteria as
identified in a Coomassie stained gel (Figure 5-5). Cattle β2m was detected by Western
blotting with anti-mouse β2m polyclonal antibody (Figure 5-4). We were not able to
detect the NC3*00101 heavy chains with the W6/32 antibody in Western blots as W6/32
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only recognized N*01701 and NC1*00501 heavy chains and not other cattle class I
heavy chains (Figure 5-4)). W6/32 and anti-mouse β2m antibodies did not react with
refolded biotinylated MHC
MHC-peptide complexes. Refolded complexes were treated with
streptavidin and run on the gel followed by Coomassie staining. We noticed the
streptavidin band in a biotinylation
iotinylation shift assay but we did not see the expected heavy
chains (~45 kD) in streptavidin negative lanes as highlighted with the oval region of
Figure 5-5. As the W6/32 antibody did not react with NC3*00101 heavy chain
(NC3*00101-HC) on Western
estern blot
blots, it was not a surprise to see that this antibody failed
to identify NC3*00101-streptavidin
streptavidin complexes. Native conditions did not produce
positive results. Therefore, we proceeded to test our peptides in peptide binding assays.

Fig 5-4:
4: Western blotting showing that W6/32 recognizes N*01701 and NC1*00501
proteins in whole cell lysates. Anti
Anti-mouse β2m antibody identifies cattle β2m inclusion
bodies.
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Fig 5-5: Biotinylation shift assay. SDS-PAGE stained with Coomassie stain to test the
refolded MHC-peptide-β2m complexes. As shown NC3*00101 heavy and β2m light
chains were expressed and purified as inclusion bodies.

Peptide Binding Assay
In peptide binding assays, treatment of cells with DMSO produced an increase in
the expression of MHC-I protein. As seen in overlays the expression of NC3*00101 was
increased by all of our peptides tested (Figure 5-6). However, the increases in the shift
varied from batch to batch. An overall comparative analysis of mean fluorescence values,
we found that the peptide EVTNQLVVL increased the NC3*00101 expression compared
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with other peptides and DMSO treatments. Other peptides, LVDGVKRIL,
SSKIVGDLA, and GSILSGTAIA were not consistently effective in increasing the shift
as EVTNQLVVL. However, we also noticed increase in expression with YPAIPVLQI
treatment, which may be because this peptide fits in the peptide-binding groove stably
because of its specificity with MHC-I proteins.
Using Proc mixed program of SAS we identified that the peptide EVTNQLVVL
had the highest least square mean among all. We identified that the EVTNQLVVL
peptide was significantly different from control DMSO. Other three NC3*00101-celleluted peptides were significantly lower than both DMSO and EVTNQLVVL. Therefore,
we conclude that EVTNQLVVL is a potential peptide for NC3*00101 protein (see Table
5-1).

Discussion
Identification of NC3*00101-specific peptide motifs is the first endeavor to
elucidate the amino acid residues binding to NC3*00101 binding groove. It is critically
important to understand peptide binding characteristics of cattle NC3*00101 protein to
gain more knowledge about mechanisms of interactions of NC3*00101 protein with other
leukocytes and the receptors expressed by leukocytes. Here we present a peptide motif
that increased the expression of NC3*00101 proteins on transfected K562 cells and was
significantly different from other peptides tested. After initial failures of
immunoprecipitation method using W6/32 antibody, we switched to citrate shock method
to elute NC3*00101-peptides from its transfected cells.
We tested four candidate peptides which were eluted from NC3*00101expressing K562 cells after citrate-acid treatment. Based on results of refolding and
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Fig 5-6:
6: Peptide binding assay performed on NC3*00101
NC3*00101-transfectants
transfectants with peptides (P1:
YPAIPVLQI; P2: EVTNQLVVL; P3: LVDGVKRIL; P4: SSKIVGDLA; P5:
GSILSGTAIA). X axis:: L
Log fluorescence and Y axis: Cell
ell count. Cells were incubated
with (red line)) and without ((black filled histogram) peptides for 15-16
16 hour at 37°C
37 and
checked for the MHC-II (NC3*00101) expression using W6/32 antibody.
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Table 5-1: The Mixed Procedure (SAS) output showing the least square means and
contrast values for different treatments in peptide binding assay
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biotinylation shift assays, we were not able to detect refolded NC3*00101-peptide-β2m
complexes. We do not have a functional antibody, which recognizes monomeric, dimeric,
trimeric and tetrameric complexes of NC3*00101-peptide- β2m. Natural ligands binding
to HLA-E are different than experimentally-derived amino acid residues [27]. It is
possible that NC3*00101-specific ligands may bind with endogenous peptides with
varying degree of similarity with residues identified in the present study. Nevertheless,
treatment of cells with peptides in peptide binding assay shows that the peptide
EVTNQLVVL increases the NC3*00101 expression more consistently.
It was not experimentally feasible to screen an entire peptide library based on the
LC-MS/MS results. Therefore, it may further need to screen larger number of peptide
library to confirm positions of anchor and auxiliary residues of NC3*00101-specific
peptides. However, unavailability of antibody to immunoprecipitate native NC3*00101
protein may present a caveat. Reports on HLA-G and other non-classical class I peptides
[6] suggest presence of non-polar or neutral amino acid at the carboxyl terminals. Nonpolar amino acids are Alanine (A), Isoleucine (I), Leucine (L), Phenylalanine (F), Valine
(V), Proline (P), and Glycine (G). By comparing with peptide motifs of human MHC-Ib
proteins, HLA-E and HLA-G, we know that experimentally derived amino acid residues
may not always be the binding motifs of MHC-I proteins. Therefore, we are confident
that NC3*00101-specific peptide motif has a valine as anchor residues at position 2, a
Val/Iso/leu at position 8, and Iso/Leu at position 9 as anchor residues (Table 5-2).
In order to further confirm that P2 (EVTNQLVVL) is NC3*00101-specific ligand, we
identified and statistically tested effects of treatment of each peptide on the NC3*00101
expression with statistical analysis software (SAS) mixed Procedure (Proc Mixed).
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Table 5-2: NC3*00101 Peptide Binding Motifs and a comparison with HLA-G and HLAE peptide motifs
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The SAS output revealed that the treatment effect was significant between different
treatments (Table 5-1). Using contrast method, we identified that treatment effect was
divided into two groups, one group containing P1 and P2 which has higher mean
fluorescence and the other group containing P3, P4, and P5 which have lower
fluorescence as compared to DMSO. The mixed procedure contrast output values reveal
that P1 (YPAIPVLQI) and P2 (EVTNQLVVL) as well as P3 (LVDGVKRIL), P4
(SSKIVGDLA), and P5 (GSILSGTAIA) are not significantly different than the control
(DMSO). However, it is clear that P1 and P2 are significantly different than P3, P4, and
P5. Differences of least square means in the table are in accordance with our hypothesis
that P2 is significantly higher than DMSO with an adjusted P value of 0.0231 (<P=0.05)
whereas P1 is not (P=0.9146). P3, P4, and P5, on the other hand, are significantly lower
than DMSO. This suggests that P2 is the most likely candidate peptide motif of
NC3*00101 protein.
In the pursuit of an antibody to detect folded MHC-peptide-β2m complexes, we
tested W6/32 and anti-mouse β2m antibodies. Monoclonal antibody W6/32 recognizes
heavy and light chain conformational epitope under non-reducing conditions. Other
reports have been published showing that W6/32 detects certain allelic forms of rabbit,
rat, mouse, and guinea pig class I heavy chains only when they are complexed with
human or cattle β2m and not with autologous β2m [16, 17, 19, 20, 26]. Therefore, it is
possible that cattle class I heavy chains which are not detected with W6/32 may require
an association with β2m from other species for their detection with W6/32. We also
identified that W6/32 only recognized N*01701 and NC1*00501 free heavy chains under
partially denaturing conditions which suggests that all cattle class I proteins do not have
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identical association of heavy and light chains which can produce variations in the
formation of class I alpha chain loops and normal peptide binding characteristics.
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CHAPTER 6
CONCLUSIONS

The first objective of this study was to elucidate and identify whether cattle nonclassical major histocompatibility complex class I (MHC-Ib) proteins are expressed as
cell-surface and/or secreted isoforms. Transfection studies were conducted to express two
classical MHC-I proteins, N*01701 and N*01802, and five non-classical MHC-I
proteins, NC1*00401, NC1*00501, NC2*00102, NC3*00101, and NC4*00201, in
murine P815 and human K562 cells. We identified that both class Ia and three class Ib
proteins, NC1*00501, NC3*00101, and NC4*00201, are expressed on the cell surface.
Two additional isoforms, NC1*00401 and NC2*00102, were not detected on the surface
of these cells. It is possible that NC1*00401 and NC2*00102 are expressed as secreted
isoforms and play important roles in immunosuppression during pregnancy.
Nevertheless, all the proteins were detected in crude cell lysates on Western blots.
Precipitation of proteins from culture supernatants showed that cell-surface MHC-Ia and
MHC-Ib proteins are shed or released from the surface of these cells into the media.
One of the cattle class Ib proteins, NC4*00201, was identified on the cell-surface
of human K562 cell line but not on murine P815 cells, which suggests that this protein
associates with human beta-2-microglobulin (β2m) and conforms better with human β2m
than with murine β2m in P815 cells.
The second objective of the present study was to develop an enzyme-linked
immunosorbent assay (ELISA) to quantitate secreted and/or soluble cattle class Ib
proteins from trophoblast cell culture supernatants. We collaborated with the monoclonal
antibody center at Washington State University, Pullman and produced monoclonal
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antibodies for NC1*00501 and NC3*00101 glycoproteins. We were able to produce a
positive and NC3*00101-specific hybridoma cell line secreting monoclonal antibodies to
NC3*00101 protein as tested with flow cytometry and ELISA. However, the positive
NC3*00101-specific hybridoma could not be revived. Therefore, further efforts need to
be planned and conducted in order to produce stable clones of hybridomas.
To advance our understanding of functional importance of the cattle class Ib
proteins, we identified the peptide motif of the NC3*00101 protein to generate
NC3*00101 tetramers. A tetramer is a complex of four identical MHC-peptide- β2m
complexes linked together with streptavidin and a fluorochrome. Leukocytes are stained
with tetramers to identify, enumerate, isolate and in situ stain antigen-specific T cells. As
a prerequisite to constructing NC3*00101-tetramers, we eluted and identified the peptide
motif of NC3*00101. First, we isolated NC3*00101 protein in its native conformation
with bound peptide by immunoprecipitation and eluted the peptide with acid treatment.
However, immunoprecipitation did not work as seen with poor results of liquid
chromatography mass-spectrometry (LC-MS). Therefore, we switched to citrate shock
method and treated NC3*00101-transfected K562 cells with low pH-citric acid to elute
and released peptides from the MHC proteins on the cell-surface. With the help of LCMS, we identified nonamers which were candidate peptides (EVTNQLVVL,
LVDGVKRIL, SSKIVGDLA, and GSILSGTAIA) for the NC3*00101 protein. These
peptides were ordered in synthetic forms from GenScript and tested for their specificity
to refold NC3*00101-heavy chain with a biotin tag and bovine β2m. We tested each of
the four peptides to refold NC3*00101 heavy and β2m chains. Western blots with W6/32
and anti-mouse β2m antibodies failed to detect refolded chains. We were not successful
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in detecting refolded proteins with Western blots. We further tested these peptides by
peptide binding assays. Transfected NC3*00101 cells were incubated with peptides and
analyzed to identify their effects on NC3*00101 expression. Due to inconsistent and
varying results of peptide binding assays, we analyzed the effects with a mixed procedure
of statistical analysis software (SAS). With the statistical analysis performed on mean
fluorescence values of transfected cells incubated with or without peptides, we identified
that EVTNQLVVL induces a significantly different response compared with control cells
and is a potential peptide motif of NC3*00101 protein. By understanding the peptide
ligands of non-classical class I NC3*00101 protein, we will be able to generate the
tetramers for this protein. Tetramers are valuable tools to identify the antigen-specific
leukocytes that bind to MHC proteins. NC3*00101 tetrameric complexes will be very
helpful in identifying the antigen-specific NC3*00101-specific leukocytes which will
further give an insight into different receptors expressed by the leukocytes that bind with
NC3*00101 and how the NC3*00101-receptor interaction results in immune tolerance
during pregnancy.
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